CN113774078B - Recombinant pichia pastoris strain, construction method and application thereof - Google Patents

Recombinant pichia pastoris strain, construction method and application thereof Download PDF

Info

Publication number
CN113774078B
CN113774078B CN202010516436.1A CN202010516436A CN113774078B CN 113774078 B CN113774078 B CN 113774078B CN 202010516436 A CN202010516436 A CN 202010516436A CN 113774078 B CN113774078 B CN 113774078B
Authority
CN
China
Prior art keywords
pichia pastoris
gene
strain
seq
pastoris strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010516436.1A
Other languages
Chinese (zh)
Other versions
CN113774078A (en
Inventor
周雍进
蔡鹏�
纪璐璐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN202010516436.1A priority Critical patent/CN113774078B/en
Publication of CN113774078A publication Critical patent/CN113774078A/en
Application granted granted Critical
Publication of CN113774078B publication Critical patent/CN113774078B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/905Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P5/00Preparation of hydrocarbons or halogenated hydrocarbons
    • C12P5/02Preparation of hydrocarbons or halogenated hydrocarbons acyclic
    • C12P5/026Unsaturated compounds, i.e. alkenes, alkynes or allenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01001Alcohol dehydrogenase (1.1.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01041Isocitrate dehydrogenase (NAD+) (1.1.1.41)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01042Isocitrate dehydrogenase (NADP+) (1.1.1.42)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01042Hexadecanal dehydrogenase (acylating) (1.2.1.42), i.e. fatty acyl-CoA reductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/99Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with other acceptors (1.2.99)
    • C12Y102/99006Carboxylate reductase (1.2.99.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y103/00Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/03Oxidoreductases acting on the CH-CH group of donors (1.3) with oxygen as acceptor (1.3.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y203/00Acyltransferases (2.3)
    • C12Y203/01Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01086Fatty-acyl-CoA synthase (2.3.1.86)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/03Oxo-acid-lyases (4.1.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides a recombinant Pichia pastoris strain, a construction method and application thereof. A method for constructing recombinant pichia pastoris strain producing fatty acid, comprising: constructing a polypeptide having the sequence of SEQ ID NO:1, a sgRNA expression vector pPICZ-Cas9-gFAA1 of a targeting nucleotide sequence; the sgRNA expression vector pPICZ-Cas9-gFAA1 is introduced into a Pichia pastoris strain, and KpFAA1 genes in the Pichia pastoris strain are knocked out. The invention also provides a construction method of the fatty alcohol synthesis recombinant Pichia pastoris strain and an alpha-olefin synthesis recombinant Pichia pastoris strain. The invention realizes the synthesis of the Pichia pastoris fatty acid derivative for the first time, especially the high-efficiency biosynthesis from methanol to fatty acid, expands the green conversion path of methanol, and explores the application potential of Pichia pastoris in the field of microbial cell factories.

Description

Recombinant pichia pastoris strain, construction method and application thereof
Technical Field
The invention belongs to the application fields of microbial genetic engineering and metabolic engineering, and particularly relates to a construction method, optimization and application of recombinant Pichia pastoris for producing fatty acid derivatives by utilizing methanol.
Background
The current world rapid-growing urban construction and industrialization process results in unprecedented dependence on fossil fuels, with increasing demands for liquid transportation fuels year by year. Currently, one third of the world's energy comes from petroleum feedstocks, the remainder from coal, natural gas, nuclear, hydroelectric and renewable energy (BP, 2014), while about 80% of liquid fuels come from the rapid consumption of petroleum (Floudas et al, comp. Chem., eng., 2012, 41:24-51.) reserves of petroleum resources and the problem of climate change due to greenhouse gas emissions from fossil fuel use have become one of the biggest challenges facing modern society, also contributing to the search for inexpensive renewable energy sources that can replace fossil fuels. Fuel ethanol is currently the most predominant biofuel, which can drastically reduce carbon dioxide emissions, however it presents food and economic problems, as well as the low energy density and hygroscopicity of fuel ethanol itself limit its widespread use (Hu et al open. Biol., 2019, 9: 190049.).
Fatty acid derivatives such as fatty alcohols, alkanes and alkenes, which have similar high energy density and combustion characteristics to the liquid fuels currently used, can be used as aviation and heavy truck fuels, and are a better alternative to petroleum resources than bioethanol (Sheng et al front. In addition, fatty acids and derivatives thereof are also important chemical materials, such as fatty acids, which can be used to make detergents and surfactants; fatty alcohols are widely used in the production of pharmaceuticals, cosmetics, detergents and skin care products; alpha-olefins are important feedstocks for the preparation of aviation fuels and high-end lubricating oils (Liu et al, microb. Cell. Face., 2016, 15:129; zhou et al, nat. Energy., 2018, 3:925-935.). BCC Research reports show that the global natural fatty acid market is approaching $135 billion in 2018, and this data will increase to $175 billion by 2023, with a Composite Annual Growth Rate (CAGR) of 5.4% during 2018-2023. The market size of fatty acid derivatives will increase from 69 billion dollars in 2018 to nearly 95 billion dollars in 2023 with a annual compound growth rate of 6.4% (BCC Research LLC, 2018).
Because of the structural characteristics of fatty acids and derivatives thereof, chemical synthesis methods have complex processes and high cost, and the number of natural biological sources is very limited, so that development of novel efficient production processes is needed to meet the increasing demands, and along with development of synthetic biology and metabolic engineering, a microbial cell factory is used as a production platform of fatty acids and derivatives thereof to gradually become an efficient and economic supplementary method. There is also a great deal of research currently being focused on this area, developing production platforms for different strains, such as Saccharomyces cerevisiae, E.coli, rhodococcus, etc. In E.coli, the precursor supply and consumption processes are balanced by modularized transcriptional level regulation of synthetic genes, and the protein translation efficiency is improved by modification of ribosome binding site of enzyme, and the final yield of fatty acid can reach 8.6 g/L (Xu et al Nat. Comm., 2013, 4:1409.) by fed-batch fermentation of engineering strains. In Saccharomyces cerevisiae, 1g/L fatty acid yield was achieved at shake flask fermentation level by integrating cytoplasmic citrate cleavage pathway, enhancing acetyl CoA supply, knocking out fatty acid beta oxidation pathway gene, etc., fed-batch fermentation in a bioreactor, yielding 10.4. 10.4 g/L (Zhou et al Nat. Comm., 2016, 7:11709.). On the basis, the carbon source flow to acetyl coenzyme A process is further enhanced, the transformation of coenzyme NADPH, ATP supply and the like is enhanced, and the saccharomyces cerevisiae is completely transformed into oleaginous yeast by combining with a laboratory adaptive evolution means, so that the yield of fed-batch fatty acid reaches 33.4 g/L (Yu et al cell., 2018, 174 (6): 1549-1558). In rhodococcus, firstly, by optimizing culture conditions, 82.9. 82.9 g/L of triacylglycerol can be produced, then acyl-CoA synthetase is knocked out, lipase specific folding enzyme and three lipases are overexpressed, and engineering bacteria can produce 50.2. 50.2 g/L of free fatty acid (Kim et al Nat. Chem. Biol., 2019, 15 (7): 721-729.).
The existing production substrate of fatty acid and derivatives thereof is mainly glucose, and although the glucose is an optimal carbon source of microorganisms, the glucose is derived from grains and is greatly influenced by geographical climate, economy and other factors. There is therefore a need to find a cheaper raw material for production as an alternative. Methanol is the simplest monohydric alcohol, mainly from the catalytic synthesis of by-products and natural gas in the coal chemical industry, and has mature production process, and is a renewable resource with wide sources and low cost (Price et al PNAS, 2016, 113:12691-12696.). Because the energy structure of China is characterized by oil deficiency, gas deficiency and coal enrichment, the productivity and yield of the domestic methanol are greatly increased in recent years. Compared with the conventional fermentation substrate saccharides, the methanol has stronger reducing power, can provide more driving force for the synthesis of heterologous products (Whitaker et al, curr. Opin. Biotechnol., 2015, 33:165-175.) and has the characteristics of low price, high volume and high energy efficiency, so that the methanol becomes a potential raw material, the existing methanol conversion route is greatly expanded by the biological refining of the methanol, and the clean utilization of coal resources is realized.
Pichia pastoris is a natural methylotrophic yeast, can grow rapidly in a methanol culture medium, can realize high-density culture, and has a mature heterologous protein expression system, so that the Pichia pastoris is a microorganism cell factory chassis with great potential. However, studies on the production of fatty acids and derivatives thereof, particularly methanol, in pichia pastoris as a substrate have not been reported. Therefore, the invention aims to construct a high-yield strain for producing fatty acid by converting methanol of pichia pastoris, on one hand, the routes of methanol utilization and fatty acid production are widened, and on the other hand, the application potential and prospect of pichia pastoris as a microbial cell factory are explored.
Disclosure of Invention
The invention aims to provide a construction method, optimization and application of Pichia pastoris for producing fatty acid, fatty alcohol and alpha-olefin.
According to the first aspect of the invention, a construction method of a Pichia pastoris strain with high fatty acid yield is provided, the capacity of producing fatty acid by cells can be remarkably improved, and the accumulation amount of fatty acid is more than 1.1 g/L.
The construction method comprises the following steps: constructing a polypeptide having the sequence of SEQ ID NO:1, a sgRNA expression vector pPICZ-Cas9-gFAA1 of a targeting nucleotide sequence; introducing the sgRNA expression vector pPICZ-Cas9-gFAA1 into a Pichia pastoris strain, and knocking out the Pichia pastoris strainKpFAA1And (3) a gene.
Wherein the pichia pastoris strain incorporates a Cas9 protein.
Optionally, the construction method further comprises: constructing a polypeptide having the sequence of SEQ ID NO:2, a sgRNA expression vector pPICZ-Cas9-gFAA2 of a targeting nucleotide sequence; introducing the sgRNA expression vector pPICZ-Cas9-gFAA2 into a Pichia pastoris strain, and knocking out the Pichia pastoris strainKpFAA2And (3) a gene.
Optionally, the construction method further comprises: constructing a polypeptide having the sequence of SEQ ID NO:3, a sgRNA expression vector pPICZ-Cas9-gPOX1 of a targeting nucleotide sequence; introducing the sgRNA expression vector pPICZ-Cas9-gPOX1 into a Pichia pastoris strain, and knocking out the Pichia pastoris strain KpPOX1And (3) a gene.
In one embodiment, the gene encoding the acyl-CoA synthetase is knocked outKpFAA1AndKpFAA2gene encoding acyl-CoA oxidaseKpPOX1
Further, the specific steps of the technical scheme are as follows: to seamlessly knock out genesKpFAA1For example, the gene editing of pichia pastoris in the present invention is primarily based on autonomously constructed CRISPR/Cas9 systems. First, a targeting gene is constructedKpFAA1The target sequence of 20 bp of the sgRNA expression vector pPICZ-Cas9-gFAA1 is a nucleotide sequence shown as SEQ ID No. 1; second, constructing donor DNA fragments, and amplifying the genes respectivelyKpFAA11000 bp sequences are respectively arranged at the upstream and downstream of the coding region, and a complete donor DNA fragment is obtained by a method of overlap extension PCR; thirdly, transforming, through an electrotransformation mode, gRNA expression vectors pPICZ-Cas9-gFAA1 and donor DNA are transformed into wild Pichia pastoris GS115, standing and culturing the wild Pichia pastoris GS115 at 30 on a YPD plate containing bleomycin for 3 days, and the transformant is subjected to YPD-zeocin + The liquid medium of (2) is cultured overnight, PCR verification is carried out, and the strain is preserved or the next experiment is carried out after the correct transformant is lost through plasmid. Knock-out geneKpFAA2AndKpPOX1(20 bp targeting sequences the nucleotide sequences shown as SEQ ID No.2 and SEQ ID No. 3) the editing process of other genes hereinafter were carried out according to similar procedures.
In one implementationIn the example, a recombinant strain of Pichia pastoris is provided, which utilizes glucose or methanol to efficiently synthesize fatty acid, the original strain is GS115, and the acyl-CoA synthetase is knocked out (from geneKpFAA1 KpFAA2Coding) and acyl-CoA oxidase (derived from a gene)KpPOX1Encoding).
In one embodiment, a recombinant strain of Pichia pastoris is provided for efficient synthesis of fatty acids using methanol, starting strain GS115, over-expressing genes from Pichia pastorisKpRAD52And knock out the fatty acyl-CoA synthetase geneKpFAA1
Further, it is identified thatKpFAA1 KpFAA2AndKpPOX1the sequence of the gene in Pichia pastoris (the nucleotide sequences shown as SEQ ID No.4, SEQ ID No.5 and SEQ ID No.6 respectively) and the function.
Further, in a basic salt culture medium with 20 g/L glucose as a carbon source, inoculating and knocking outKpFAA1 KpFAA2AndKpPOX1pichia pastoris of the gene, and fatty acid fermentation experiments are carried out. Its parameters are set to initial inoculation OD 600 At 0.1, the fermentation conditions were as follows: the liquid loading amount is 20 ml/100 ml,220 rpm,30 , and the fermentation time is 72-96 hours. Further, pichia pastoris was found and identified to accumulate mainly fatty acid species C16:1, C16, C18:2, C18:1 and C18.
In one example, the strain was fermented 96. 96 h in basal medium containing 20 g/L glucose with shake flask level fatty acid production reaching 1.1. 1.1 g/L, fatty acid species including C16:1, C16, C18:2, C18:1 and C18.
Further, in a basic salt culture medium with 20 g/L methanol as a carbon source, inoculating and knocking outKpFAA1 KpFAA2AndKpPOX1pichia pastoris of the gene, and fatty acid fermentation experiments are carried out. Its parameters are set to initial inoculation OD 600 At 0.2, the fermentation conditions were as follows: the liquid loading amount is 20 ml/100 ml,220 rpm,30 , and the fermentation time is 96-120 h. The result proves that the recombinant pichia pastoris can grow and metabolize by taking methanol as the only carbon source and energy source, and can produce about 600 mg/L fatty acid and fatThe acid species is the same as glucose.
In one example, the strain was fermented 120 h in a basal medium containing 20 g/L methanol, and shake flask level fatty acid yields reached 577 mg/L, fatty acid species including C16:1, C16, C18:2, C18:1, and C18.
According to a second aspect of the present invention, there is provided a strategy for increasing the supply of acetyl-CoA precursor and coenzyme NADPH in Pichia pastoris, over-expressing a mouse-derived citrate lyase (derived from a gene MmACLCoding), isocitrate dehydrogenase 2 (derived from the gene endogenous to pichia pastorisKpIDP2Coding), a citrate transporter derived from Saccharomyces cerevisiae (from a geneScYHM2Encoding). Thereby improving the fatty acid yield of pichia pastoris.
In one example, recombinant Pichia strains with high fatty acid production overexpressed both the citrate lyase MmAcl from mice, the citrate transporter ScYhm2 of Saccharomyces cerevisiae, and the endogenous cytoplasmic isocitrate dehydrogenase KpIDP2 of Pichia pastoris, enabling the capacity of Gao Bichi yeast to utilize methanol to produce fatty acids.
Alternatively, the pichia pastoris strain HIS4 site incorporates the protein KpRad52.
Optionally, the Pichia pastoris strain knocks out genesKpFAA1
Alternatively, the recombinant pichia pastoris strain is overexpressed by a geneMmACLThe coded citrate lyase includes gene derived from mouseMmACLIntegration into the Pichia pastoris, preferably into the yeast genome PNSI-2 site.
Alternatively, the recombinant pichia pastoris strain is overexpressed by a geneKpIDP2Coded isocitrate dehydrogenase 2 comprising a gene derived from Pichia pastorisKpIDP2Overexpression of the gene, preferably integration into the PNSI-3 site, is performed.
Alternatively, the recombinant pichia pastoris strain is overexpressed by a geneScYHM2The encoded citrate transporter includes gene derived from Saccharomyces cerevisiaeScYHM2Integration into the Pichia pastoris, preferablyIntegration into the PNSI-4 site.
In a specific embodiment, the implementation steps of the above technical scheme are as follows:
(1) GeneMmACLIs over-expressed by (2)
The specific flow is consistent with the first aspect of the invention, wherein the constructed sgRNA expression vector is pPICZ-Cas9-gPNSI-2, and the 20 bp targeting sequence is a nucleotide sequence shown as SEQ ID No. 7. Second, construction of a donor DNA for chromosomal integration, including homology arms of 1000 bp on both sides of the site and an exogenous gene expression cassette P AOX1 -MmACL-T FAA1 . Further, genesMmACLThe gene source is artificial synthesis, and the nucleotide sequence is shown as SEQ ID No. 8.
(2) GeneKpIDP2AndScYHM2is over-expressed by (2)
The specific procedure is consistent with the first aspect of the invention described above, wherein the sgRNA expression vectors constructed are pPICZ-Cas9-gPNSI-3 (wherein the nucleotide sequence of the targeting sequence of 20 bp is shown as SEQ ID No. 9) and pPICZ-Cas9-gPNSI-4 (wherein the targeting sequence of 20 bp is shown as the nucleotide sequence of SEQ ID No. 10). Further, it is identified that KpIDP2The sequence in Pichia pastoris (the nucleotide sequence of which is shown as SEQ ID No. 11) and functions. GeneScYHM2Obtained by amplification of Saccharomyces cerevisiae CENPK-113 genome (its sequence is shown as nucleotide sequence of SEQ ID No. 12).
In a third aspect of the present invention, there is provided a recombinant pichia pastoris strain producing fatty acids, constructed according to the method of the first aspect of the present application or according to the method of the second aspect of the present application.
In a fourth aspect of the present application, there is provided a construction method of a pichia pastoris strain for producing fatty alcohols, comprising: the carboxylic acid reductase MmCar and cofactor AnNpgA, alcohol dehydrogenase Scadh5, acyl-CoA reductase FaCoar were overexpressed in Pichia pastoris to construct fatty alcohol synthesis pathways.
Optionally, the pichia pastoris strain HIS4 site is integrated withKpRAD52And (3) a gene.
Optionally, the saidPichia pastoris strain seamless knock-out fatty aldehyde dehydrogenase geneKpHFD1
Alternatively, the Carboxylic acid reductase gene of Mycobacterium marinumMmCARIs integrated into the PNSI-2 locus of the recombinant Pichia pastoris strain to overexpress the carboxylate reductase MmCar.
Alternatively, a cofactor protein derived from Aspergillus nidulans AnnpgAThe gene was integrated into the PNSI-3 locus of the recombinant Pichia pastoris strain to overexpress the cofactor protein AnNpgA.
Alternatively, saccharomyces cerevisiae is used as the sourceScADH5The gene was integrated into the PNSI-4 locus of the recombinant Pichia strain to overexpress the alcohol dehydrogenase Scadh5.
Optionally, the codons are optimizedFaCoARThe gene is integrated into PNSI-5 locus of the recombinant Pichia pastoris strain to overexpress acyl-CoA reductase FaCoar.
In one embodiment, the wild-type Pichia pastoris GS115 overexpression gene is in the basal cellKpRAD52And knock out fatty aldehyde dehydrogenase geneKpHFD1Sum geneKpFAA1Further over-expressing a carboxylate reductase gene on the basal cellMmCARCofactor genesAnnpgAAlcohol dehydrogenase geneScADH5Fatty acyl-coa reductase geneFaCoARA fatty alcohol yield of 75.8 mg/L can be achieved.
In one embodiment, the 4 key genes, the carboxylate reductase genes, of the fatty alcohol synthesis pathway are synthesized by means of the CRISPR/Cas9 systemMmCARCofactor genesAnnpgAAlcohol dehydrogenase geneScADH5And an acyl-CoA reductase geneFaCoARIntegration into PNSI-2, PNSI-3, PNSI-4 and PNSI-5 sites. Wherein,MmCAR AnnpgAandFaCoARoptimizing according to the codon preference of pichia pastoris, and sequentially adopting the optimized sequences as SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, and a nucleotide sequence shown in seq id no.
The specific procedure is consistent with the first aspect of the invention, wherein the sgRNA expression vector is constructed as pPICZ-Cas9-gPNSI-5 (wherein the targeting sequence of 20 bp is the nucleotide sequence shown as SEQ ID No. 16).
Further, to increase fatty alcohol yield, genes responsible for catalyzing fatty aldehydes to fatty acids are introducedKpHFD1Seamless knockout was performed.
GeneKpHFD1The specific flow of seamless knockout is consistent with the content of the first aspect of the invention, wherein the constructed sgRNA expression vector is pPICZ-Cas9-gHFD1, and the 20 bp targeting sequence is shown in SEQ ID NO:17, and a nucleotide sequence shown in seq id no. At the same time, genes were identifiedKpHFD1Sequences in Pichia pastoris (nucleotide sequence shown as SEQ ID NO: 18) and function.
According to a fifth aspect of the present application, there is provided a recombinant pichia pastoris strain synthesized from fatty alcohol constructed according to the construction method of the fourth aspect of the present application.
According to a sixth aspect of the present application, there is provided a method of constructing a recombinant Pichia pastoris strain for -olefin synthesis, the fatty acid decarboxylase gene being a critical step in the processPfUndB(the nucleic acid sequence of which is shown as SEQ ID NO: 19) and cofactor protein gene thereofCamA(the nucleic acid sequence of which is shown as SEQ ID NO: 20) and CamB(the nucleic acid sequence of which is shown as SEQ ID NO: 21) was codon optimized. Overexpression of genes in high fatty acid-producing strainsPfUndBAnd two cofactor protein genes thereofCamAAndCamBthe biosynthesis of 15 carbon and 17 carbon alpha-olefins in Pichia pastoris is realized for the first time.
Further, targeting the cofactor protein with the decarboxylase for peroxisome expression increases the alpha-olefin by a factor of two.
Further, two other codon-suitability-optimized fatty acid decarboxylase genes are overexpressed in chassis cells containing cofactor proteins CamA and CamBPpUndA(the nucleic acid sequence of which is shown as SEQ ID NO: 22) andJeOleT(the nucleic acid sequence is shown as SEQ ID NO: 23), and the biosynthesis of alpha-olefin in Pichia pastoris is realized.
In one embodiment, the gene is knocked out as described in the first aspect of the present applicationKpFAA1The recombinant pichia pastoris strain producing fatty acid is used as an original strain, so that the recombinant pichia pastoris strain overexpresses cofactor eggsWhite geneCamAAndCamBfurther over-expression of fatty acid decarboxylase genesPfUndB PpUndAOr (b)JeOleTOne or more of (a)
According to a seventh aspect of the present application there is provided a construction method according to the first or second aspect of the present application, a recombinant pichia pastoris strain for fatty acid production according to the third aspect of the present application, a construction method according to the fourth aspect of the present application, a recombinant pichia pastoris strain for fatty alcohol synthesis according to the fifth aspect of the present application, and use of the recombinant pichia pastoris strain for cell mass cultivation of the sixth aspect of the present application.
According to an eighth aspect of the present application there is provided a construction method according to the first or second aspect of the present application, a recombinant Bi Basi d erythro strain producing fatty acids according to the third aspect of the present application, a construction method according to the fourth aspect of the present application, a recombinant pichia pastoris strain synthesizing fatty alcohols according to the fifth aspect of the present application and the use of a recombinant pichia pastoris strain synthesizing alpha-olefins according to the sixth aspect of the present application in the synthesis of fatty acids and/or fatty alcohols and/alpha-olefins.
The beneficial effects that this application can produce include:
1) The application provides a construction method of a recombinant Bi Basi d erythrocyte strain for producing fatty acid, which comprises the steps of firstly knocking out fatty acyl-CoA synthetase (from genes) in a fatty acid beta oxidation pathwayKpFAA1KpFAA2Coding) and acyl-CoA oxidase (derived from a gene)KpPOX1Code) can greatly improve the accumulation capacity of pichia pastoris fatty acid, 96 h can be fermented in a shake flask containing 20 g/L glucose as a basic component medium, the yield of the fatty acid can reach 1.1 g/L, and the types of the fatty acid are mainly C16:1, C16, C18:2, C18:1 and C18. In order to explore the green conversion of a carbon resource, fatty acid fermentation with methanol as the only carbon source is performed, and the yield can reach 577 mg/L. By overexpressing the citrate lyase Aclp from mice, the citrate transporter Yhm of Saccharomyces cerevisiae and the endogenous cytoplasmic isocitrate dehydrogenase gene Idp2 of Pichia pastoris, the synthesis of acetyl-CoA in the cytoplasm is enhanced and to some extent The cell reducing power NADPH is supplemented. The final yield of fatty acid produced by methanol conversion is improved by 2.4 times compared with the control through the synergistic effect of a plurality of enzymes.
2) The application also provides a construction method of the fatty alcohol synthesis recombinant Bi Basi erythrocyte strain, which enables genes to be formed through a chromosome integration wayMmCAR npgA ADH5AndFaCoARthe fatty aldehyde dehydrogenase Hfd1 endogenous in the pichia pastoris is overexpressed and knocked out in the recombinant Bi Basi denominator strain, the synthesis of fatty alcohol is realized in the pichia pastoris for the first time, the yield of fatty alcohol under the glucose condition reaches 75.8mg/L, and the synthesis of fatty alcohol is also realized when methanol is taken as the sole carbon source.
3) The application also provides a construction method of the alpha-olefin synthesis recombinant Bi Basi d erythrocyte strain, which expresses fatty acid decarboxylase UndB, undA or OleT by a free vector in a high-yield fatty acid chassis cell with chromosome integrated cofactor proteins CamA and CamB, and realizes the synthesis of the alpha-olefin for the first time.
4) The invention realizes the synthesis of the Pichia pastoris fatty acid derivative for the first time, particularly the efficient biosynthesis of methanol to fatty acid, expands the green conversion path of methanol, and explores the application potential of the Pichia pastoris in the field of microbial cell factories
Drawings
FIG. 1 is a schematic representation of the process of construction of sgRNA in the Pichia pastoris CRISPR/Cas9 system.
FIG. 2 shows the construction of a Pichia pastoris strain for high fatty acid production.
FIG. 3 is a schematic representation of a metabolic engineering strategy to promote accumulation of Pichia pastoris fatty acids.
FIG. 4 shows fermentation of Pichia pastoris fatty acid under minimal medium conditions with 20 g/L glucose as substrate.
FIG. 5 shows fermentation of Pichia pastoris fatty acid with 20 g/L methanol as substrate in basal medium.
FIG. 6 shows an overexpressed geneMmACL KpIDP2AndScYHM2effect on fatty acid production.
FIG. 7 shows fatty alcohol synthesis strain construction.
FIG. 8 shows fermentation of Pichia pastoris fatty alcohol under basal medium conditions with 20 g/L glucose as substrate.
FIG. 9 shows fermentation of Pichia pastoris fatty alcohol in basal medium with 20 g/L methanol as substrate.
FIG. 10 shows a schematic of the construction of the alpha-olefin synthesis pathway.
FIG. 11 shows a gas chromatogram of the analysis of recombinant Pichia pastoris synthesized alpha-olefin products.
Detailed Description
The following non-limiting examples will enable those of ordinary skill in the art to more fully understand the invention and are not intended to limit the invention in any way. In the following examples, unless otherwise specified, all experimental methods used are conventional and all materials, reagents and the like are commercially available from biological or chemical companies.
Example 1
Construction of Pichia pastoris strains with high fatty acid yield
(1) Gene editing CRISPR/Cas9 system construction
The starting strain Pichia pastoris (Komagataella phaffii GS 115) was given by the university of North America Cai Menghao. The construction process of the sgRNA expression vector is shown in FIG. 1, and all the sgRNA expression vectors used in the invention are completely identical except for the 20 bp targeting sequence. Obtaining a pPICZ-Cas9 plasmid skeleton through PCR amplification, and simultaneously respectively introducing enzyme cutting sites KpnI and SpeI at two ends of the skeleton to facilitate the replacement of a gRNA part sequence of a subsequent experiment; next, P was amplified by two long primers, respectively HTX1 And a sgRNA portion fused by overlap extension PCR to form a complete sgRNA expression cassette. Wherein the primers of the amplification sequences on both sides are immobilized as HTX1-Cas9-F (GGAGTACTTCTTGTCCATCGTTTCGACTAGTTGTTGTAGTTTTAATATAGTTTGAGTATGAGATGGAACTC) and AOX1t-Kpn-ARS-R (AAACGTCAAATCATAATCAGCACTAGGTACCGCACAAACGAACGTCTCACTTAATCTTC), and the reverse complementary sequences of 6bp in gRNA20 bp and HH are changed by a pair of long primers in the middle, and HTX1-Cas9-F and gFAA1-R (GTTTCGTCCTCACGGACTCATCAGTGAACGTTTGATTTGTTTAGGTAACTTGAAC TGGATGTATTAGTTTGG) amplification of P HTX1 Part, gFAA1-F (CGTTCACTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCTGAACGACATGAAGACAACAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCT) amplified the sgRNA part with AOX1 t-Kpn-ARS-R. Genes obtained after fusionKpFAA1The sgRNA expression cassette and the vector skeleton are connected through T4 DNA ligase, and are transformed into escherichia coli, and further PCR identification and sequencing verification are carried out to obtain the correct recombinant sgRNA plasmid for subsequent experiments.
The sgRNA expression vector involved in the present invention includes pPICZ-Cas9-gFAA1 (targeting gene)KpFAA1) pPICZ-Cas9-gFAA2 (targeting gene)KpFAA2) pPICZ-Cas9-gPOX1 (targeting gene)KpPOX1) pPICZ-Cas9-gPNSI2 (targeting chromosomal site PNSI 2), pPICZ-Cas9-gPNSI3 (targeting chromosomal site PNSI 3) and pPICZ-Cas9-gPNSI4 (targeting chromosomal site PNSI 4).
The Donor DNA construction is shown in FIG. 2. Firstly, respectively amplifying 1000 bp sequences on the upstream and downstream of a target gene coding region or a target site as homology arms, and then sequentially connecting all parts of the DONOR DNA by a fusion PCR (polymerase chain reaction) mode to obtain the complete DONOR DNA for a subsequent electrotransformation experiment to obtain a gene editing effect.
(2) Construction of high fatty acid-producing Strain
The synthesis and catabolic pathways of fatty acids in yeast cells are shown in FIG. 3, the fatty acids are synthesized via acetyl CoA via carbon chain extension, and applicants have found that by blocking the activation step of fatty acids in the beta-oxidation pathway of Saccharomyces cerevisiae fatty acids, i.e., knocking out acyl CoA synthetase (from the geneKpFAA1AndKpFAA4coding) and acyl-CoA oxidase (derived from a gene)KpPOX1Encoding) can be used to obtain a certain amount of fatty acid accumulation and prevent degradation of fatty acids. By comparing nucleotide and protein sequences, the corresponding acyl-CoA synthetase is found in Pichia pastorisKpFAA1AndKpFAA2) And acyl-CoA oxidaseKpPOX1
Based on the above, to construct a pichia pastoris strain with high fatty acid production, we first performed on the following with the aid of CRISPR-Cas9 gene editing systemKpFAA1 KpFAA2The single knockout and the double knockout of two genes are carried out, and the strain PC101 is respectively constructedKpFAA1Singly knock out), PC102 #KpFAA2Single knockout) and PC103KpFAA1AndKpFAA2double knockout). Subsequently, further steps were performed on the basis of the PC101 and PC103 strainsKpPOX1Seamless knockout of the gene resulted in engineering strains PC105 and PC106, respectively. This series of strains was used for subsequent testing of fatty acid productivity.
Example 2
Fatty acid fermentation of recombinant pichia pastoris strains
(1) Culture medium
YPD medium: 20 g/L glucose, 20 g/L peptone, 10 g/L yeast powder;
fermentation medium (basal medium): (NH) 4 ) 2 SO 4 2.5 g/LKH 2 PO 4 14.4 g/LMgSO 4 7H 2 O0.5 g/L, histine 40 mg/L, add about 800 mL ddH 2 O, stirring and dissolving, regulating pH to 5.6 with KOH, fixing volume to 950 mL, and regulating pH to 115 o C, sterilizing for 30 min. After sterilization, 2 mL trace metal solutions and 1 mL vitamin solution were added. Different kinds of carbon sources, including 20 g/L glucose or 20 g/L methanol, were added to the fermentation medium for fatty acid fermentation.
(2) Fermentation process and conditions
Strain activation, 3 single colonies were picked from YPD streak plates in 3/15 mL YPD medium, or in Deft-G medium, 220 rpm,30 o C, shake culturing overnight, not more than 20 h; inoculating by fermentation according to initial OD 600 =0.1 (inoculated in Deft-G medium), or OD 600 =0.2 (shift-M medium). Conical flask with liquid loading of 20 mL/100 mL, 220 rpm,30 o And C, fermenting under the condition of C. Site-directed sampling was used for biomass (expressed as absorbance at 600 nm) and fatty acid yield analysis.
(3) Fatty acid synthesis
Successful construction is obtainedKpFAA1 KpFAA2AndKpPOX1after seamless gene knockout, we first performed under the conditions of Deft-G medium Fermentation experiments of fatty acids were performed. The experimental results are shown in FIG. 4. The fermentation process 96 h is finished, the biomass is basically not different under the condition of glucose culture, and the end point OD value is about 15, regardless of the wild type strain or the engineering strain. In terms of fatty acid accumulation, the number of the fatty acid accumulated was increased by a certain amount in comparison with the wild type strain, with the number of the knocked-out genes being increased, and the fatty acid yield was more than 1 g/L. In the Pichia pastoris, the types of fatty acids accumulated in the Pichia pastoris are mainly C16:1, C16, C18:1, C18:2 and C18, wherein three kinds of fatty acids of C16, C18:1 and C18:2 are taken as main materials, and the fatty acids account for more than 80% of the total yield of the fatty acids.
Subsequently, we performed fatty acid fermentation experiments on the Deft-M medium, the results of which are shown in FIG. 5. The initial carbon source amount is 10 g/L methanol, and 10 g/L methanol is added when about 48 h is fermented and cultured. The biomass of the Pichia pastoris engineering strain with the gene knocked out in the fermentation process 120 h is approximately similar no matter how many genes are knocked out, and the DO value reaches about 9. The wild type strain was similar to glucose medium in terms of fatty acid yield, with only small amounts of fatty acid accumulated. Knock-out KpFAA1After the gene, more fatty acid accumulation is obtained, the yield exceeds 200 mg/L,KpFAA1 KpFAA2andKpPOX1the triple knockout strain obtained the maximum fatty acid yield under methanol culture conditions, reaching 577 mg/L. During methanol culture, the main types of accumulated fatty acids are consistent with glucose, namely C16:1, C16, C18:1, C18:2 and C18, wherein the proportion of C16:1 is slightly increased. The invention realizes the efficient synthesis of the one-carbon resource methanol to the long-chain fatty acid for the first time.
Example 3
Enhancement of the acetyl-CoA synthetic pathway
acetyl-CoA is a very important intermediate of basal energy metabolism and is also a direct precursor for the synthesis of fatty acid compounds by yeast cells. A substantial increase in fatty acid synthesis may lead to intracellular acetyl-coa deficiency. In addition to the entry of pyruvate from the glycolytic pathway into mitochondria to acetyl-CoA, a set of citrate lyase (ACL) systems, lines, are present in microorganismsThe citrate produced in the granules can cross the inner mitochondrial membrane and be broken down in the cytosol by the action of citrate lyase, yielding acetyl-coa and oxaloacetate. Applicants have found that overexpression of the citrate lyase gene derived from mice MmACLWhen the fatty acid yield is increased by 19.4%. In Saccharomyces cerevisiaeYHM2The gene coded protein is responsible for transporting the citric acid in mitochondria into cytoplasm, simultaneously transporting alpha-ketoglutarate in cytoplasm into mitochondria to participate in citric acid circulation, and overexpressing genesYHM2Also beneficial to fatty acid synthesis (Yu et al cell., 2018, 174:1549). Since fatty acid biosynthesis consumes a large amount of cellular reducing NADPH, especially when methanol is used as a substrate, a strong pentose phosphate pathway is lacking, intracellular NADPH is severely deficient, which may be one of the reasons for lower production of methanol as a substrate than glucose. Isocitrate dehydrogenase 2 (derived from GeneIDP2Code) is responsible for the conversion of cytoplasmic citrate to alpha-ketoglutarate, with the production of an NADPH, which allows the circulation of citric acid inside and outside the mitochondria, also favoring the production of fatty acids (Yu et al cell., 2018, 174:1549.). Therefore, we overexpress the citrate lyase gene from mice in Pichia pastorisMmACLCitric acid trans-mitochondrial membrane transporter gene derived from saccharomyces cerevisiaeScYHM2Isocitrate dehydrogenase gene derived from Pichia pastoris endogenous KpIDP2
Since Pichia pastoris belongs to non-traditional yeast, the repair process is mainly non-homologous end connection, and homologous recombination is difficult to occur, and therefore, the over-expression initial strain of the exogenous gene is enhanced by homologous recombination (high expressionKpRAD52The nucleotide sequence of the gene is shown as SEQ ID No. 24) and the engineering strain improves the gene editing efficiency. The starting strain GS115 used was a His auxotrophic strain, and thereforeHIS4The gene can be used as a target point of gene overexpression. First, similar to example 1, the HTX1 promoter portion was amplified using primers HTX1-Cas9-F and gHIS4-R (GTTTCGTCCTCACGGACTCATCAGAACGAGTTTGATTTGTTTAGGTAACTTGAACTGGATGTATTAGTTTG), gHIS4-1-F (CTCGTTCTGATGAGTCCGTGAGGACGAAACGAGTAAGCTCGTCAACGAGAGCAGACTACACCAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCT) amplifying the sgRNA fraction with AOX1 t-Kpn-ARS-R. Genes obtained after fusionHIS4The sgRNA expression cassette and the vector skeleton are connected through T4 DNA ligase to construct the sgRNA expression vector pPICZ-Cas9-gHIS4 (wherein the targeting sequence of 20 bp is a nucleotide sequence shown as SEQ ID No. 25).
When constructing an integrated Donor DNA, a pair of primers PpRad52-GAPp-F (TTCAATCAATTGAACAACTATCAAAACACAATGTCTTTCGATGACGCTGAGC) are first used
PCR amplification with PpRad52-AOX1t-R (AGGCAAATGGCATTCTGACATCCTCTTGATTAATTCGAAGCTGGAGAGTTTTCTTTTCCT) to obtain Pichia pastoris endogenousKpRAD52The gene sequence is subjected to overlap extension PCR and promoter P GAP And terminator T AOX1 Fusion to obtain the Rad52 protein expression cassette. Then the homologous arm region sequences of 1000 bp respectively at the upstream and downstream of the Pichia pastoris HIS4 gene are obtained by the same PCR amplification method, and the complete sequence is obtained again by the fusion PCR methodKpRAD52The gene overexpresses the donor DNA, and subsequent transformation and identification steps are the same as in example 1, thereby obtaining a pichia pastoris recombinant strain that overexpresses the Rad52 protein and thereby enhances homologous recombination.
Based on the above, knockout is carried outKpFAA1. The engineering strain uses methanol as the only carbon source to carry out fatty acid fermentation performance detection, the fermentation conditions and the detection method are consistent with the embodiment 2 of the invention, and the result is shown in figure 6. Overexpression of genes alone at PNSI-2 locusMmACLDuring the process, the synthesis path of acetyl coenzyme A in cytoplasm is enhanced, and the yield of fatty acid is increased by 19.1% compared with that of the original strain, and reaches 206 mg/L. Continuing to overexpress the gene on the basisKpIDP2The supply of cellular NADPH is compensated to a certain extent, and the yield of fatty acid is improved by 24.3 percent compared with that of PC 115. Finally, the citric acid transporter ScYHM2 of the saccharomyces cerevisiae from an over-expression source enhances the upstream step of acetyl coenzyme A, strengthens the citric acid transport and metabolic process of cytoplasm and mitochondria, ensures that the yield of fatty acid reaches 410 mg/L in the key point of the fermentation process, improves the metabolism transformation in the last step by 60.5 percent, and is 2.4 times of the yield of the original strain.
Example 4
Synthesis of fatty alcohol from pichia pastoris
(1) Construction of fatty alcohol Synthesis Strain
Saccharomyces cerevisiae (Zhouet al J. Am. chem. Soc., 2016, 138 (47): 15368-15377.) was previously constructed in the laboratory to produce fatty alcohols, on the basis of which we selected 4 key genes of the fatty alcohol synthesis pathway, the alcohol dehydrogenase geneScADH5Fatty acyl-coa reductase geneFaCoARCarboxylic acid reductase geneMmCARCofactor genesAnnpgAExpression (FIG. 7) was performed, and it was desirable to be able to achieve the synthesis of fatty alcohols in Pichia pastoris. At the same time, the key genes are selectedFaCoAR(the nucleotide sequence is shown as SEQ ID NO: 13),MmCAR(nucleotide sequence is shown as SEQ ID NO: 14) andnpgA(the nucleotide sequence is shown as SEQ ID NO: 15) the codon optimization is carried out. The FAA1 gene of Pichia pastoris is knocked out firstly by means of a Pichia pastoris CRISPR-Cas9 system established in the early stage of a laboratory so as to realize accumulation of fatty acid, and the knocking-out method is the same as that of the embodiment 1. Also, the basis of laboratory preliminary study is used for geneKpHFD1Seamless knockouts are made that catalyze the reverse reaction of fatty aldehydes to fatty acids. Can effectively prevent fatty aldehyde from being reoxidized after knocking out, and increase the supply of precursor substances for fatty alcohol synthesis. Thus, before constructing fatty alcohol pathway, first to KpHFD1Knocking out genes to obtain the recombinant chassis strain. Finally, the 4 genes are integrated into PNSI-2, PNSI-3, PNSI-4 and PNSI-5 sites by complete expression cassettes, and a fatty alcohol synthesis pathway in Pichia pastoris is constructed.
(2) Fatty alcohol fermentation experiment of Pichia pastoris
The fermentation process and parameters were essentially the same as in example 2, and after obtaining the correct recombinant strain, fermentation analysis of the fatty alcohol production of the strain was first performed in a basal medium containing 20 g/L glucose, and 2ml of fermentation broth was taken at the end of the 72 h fermentation and analyzed. As shown in FIG. 8, the constructed recombinant Pichia pastoris strain successfully realizes the biosynthesis of fatty alcohol, and the main fatty alcohol products are C16-1-OH, C16-OH, C18-1-OH and C18-OH, wherein the yield of C18-1-OH can be close to 30 mg/L, so that the recombinant Pichia pastoris strain is the fatty alcohol with the highest yield, and the total fatty alcohol yield of Pichia pastoris reaches 76 mg/L, so that the recombinant Pichia pastoris strain is the highest yield in Pichia pastoris at present.
The potential of recombinant pichia pastoris for producing fatty alcohol by taking methanol as a substrate is also explored, and fermentation analysis of fatty alcohol production of recombinant pichia pastoris strains is carried out in a basic component culture medium containing 20 g/L methanol. As shown in FIG. 9, the constructed recombinant Pichia pastoris strain also successfully realizes the synthesis of fatty alcohol by using methanol, and compared with the glucose culture condition, the main fatty alcohol product type has no C16-1-OH detected, and the other three fatty alcohols can be successfully detected. When the recombinant strain methanol is used as a carbon source, the total yield of fatty alcohol is about 3 mg/L.
Example 5
Synthesis of alpha-olefin by pichia pastoris
Long-chain (C12-C20) alpha-olefins are mono-olefins with double bonds at molecular chain ends, and are important raw materials for preparing various chemical products such as aviation fuels, plasticizers, high-performance synthetic lubricating oil, detergents, fragrances and the like. The recombinant pichia pastoris strain with high fatty acid yield is successfully constructed in the early stage, the embodiment further converts the fatty acid into alpha-olefin, and the pichia pastoris is expanded to be used as a product catalog of a microbial cell factory. Pre-laboratory screening to a sourcePseudomonas fluorescens Pf-5Fatty acid decarboxylase genes of (2)PfUndBThe Saccharomyces cerevisiae engineering bacteria with the exogenesis introduced into the high-yield fatty acid can realize the biosynthesis of long chain alpha-olefin (Zhou et al ACS. Synth. Biol., 2018, 7:584-590.).
The high-yield fatty acid strain PC101 constructed in the earlier stage is taken as an initial strain, and the cofactor protein gene is overexpressedCamAAndCamBP ADH2 the driving expression is integrated into PNSI-3 and PNSI-4 sites to construct chassis cells. Fatty acid decarboxylase genesPfUndB PpUndAAnd JeOleTFrom the strong promoter P GAP Expression was driven, integrated into PNSI-5 sites (as shown in FIG. 10), and the correct recombinant strain was screened for use in alpha-olefin fermentation detection experiments. The fermentation conditions were the same as in example 2, with an initial inoculation OD of 0.1 at 30in a basal medium containing 20 g/L glucose, 220 72 h were cultured at rpm. After fermentation, 5 mL broth was collected, centrifuged to remove supernatant, and resuspended in 1 mL ddH2O and lyophilized. Chloroform was used: methanol=2: 1 as extractant, 1 mg/L hexadecane as internal standard, and gas chromatography to detect alpha as olefin yield. The supernatant was extracted with 2. 2 ml, 1. 1 ml of n-hexane containing 1. 1 mg/L hexadecane as an internal standard, and the product was analyzed by gas chromatography.
As a result of the experiment, as shown in FIG. 11, a fatty acid decarboxylase gene was expressedPfUndBAnd cofactor protein genes thereofCamAAndCamBthe synthesis of alpha-olefins was successfully detected by pichia pastoris strains. The gas chromatographic analysis results show that the alpha heptaolefin of the 1-pentadecene and the 1-heptadecene respectively show peaks at 18.4 min and 20.7 min, which are consistent with the standard substance. The product was then subjected to GC-MS detection, further verifying that the peak was indeed the target product.
Since the direct precursor of alpha-olefins is a fatty acid and peroxisomes are one of the main sites where beta oxidation of fatty acids occurs, it is possible to further increase the yield of alpha-olefins by targeting the synthetic pathway of alpha-olefins to peroxisomes. The localization expression of peroxisome can be realized by adding short peptide SKL at the C end of protein. Therefore, the experiment constructs a alpha-olefin synthesis path of the targeted peroxisome by connecting SKL positioning short peptide at the C end of cofactor protein and three fatty acid decarboxylases through GGGS, and the targeted peroxisome can be found out by fermentation detection, so that the yield of the alpha-olefin can be improved by the targeted peroxisome, thereby PfUndBFor example, the alpha-olefin yield is doubled, reaching about 2.5 mg/L. Furthermore, since PfUndB is a membrane chimeric protein, some of the product is transported to the outside of the cell, whereas production of the product -olefin is not detected by the outside of the cell when the recombinant strain of PpUndA is fermented. The catalytic effect of PfUndB was the best among the three decarboxylases.
The example results confirm that the pichia pastoris can realize the synthesis of alpha-olefin through expressing fatty acid decarboxylase and cofactor protein for the first time, verify that various fatty acid decarboxylase can play a role in the pichia pastoris, explore the feasibility of developing the pichia pastoris as a high-efficiency microbial cell factory for producing fatty acid derivatives, and lay an experimental foundation.
The foregoing description is only a few examples of the present application and is not intended to limit the present application in any way, and although the present application is disclosed in the preferred examples, it is not intended to limit the present application, and any person skilled in the art may make some changes or modifications to the disclosed technology without departing from the scope of the technical solution of the present application, and the technical solution is equivalent to the equivalent embodiments.
Sequence listing
<110> institute of chemical and physical of Dalian of academy of sciences of China
<120> a recombinant Pichia pastoris strain, construction method and application thereof
<130> DD200234I
<141> 2020-06-08
<160> 25
<170> SIPOSequenceListing 1.0
<210> 1
<211> 20
<212> DNA
<213> An artificial sequence
<400> 1
tgaacgacat gaagacaaca 20
<210> 2
<211> 20
<212> DNA
<213> An artificial sequence
<400> 2
gctaggtcag aagagggcaa 20
<210> 3
<211> 20
<212> DNA
<213> An artificial sequence
<400> 3
aaaatcttgg gactttccgg 20
<210> 4
<211> 2106
<212> DNA
<213> An artificial sequence
<400> 4
atggtgtttc aagtaaatgt tcctgtgggc gaagctagaa agggtgaaac agctcccaga 60
agatactaca aggttaaaga tgcagcggtg ctcaaaccga gtgactgtaa cccgaaaact 120
gaaactgttt acgattactt ggttgaaatg tttgaacgac atgaagacaa caaggctatg 180
gcttggaggg atctcgttga tattcatact gagaagaaga aggtcaacaa aatgattgat 240
ggtgagctaa aaaatattga aaaagaatgg caatattacg aattaagtga ttacaaattt 300
atcacttaca aagagctgaa atcgataatt tttgaatatg gccggggcct tgtggaatta 360
ggtatcaagc cgaatcagga ggaacggctg catatatatg cttcaacatc acacaagtgg 420
ttccaaacat atttggcaac tcaaactcaa aacattccaa tagtaactgc gtatgacacc 480
ctcggtgaaa gtggtttaac tcattcttta gtgcagacag gttctgtggc gattttcacc 540
aacaatgacc ttcttcacac tctcatcaac ccgttgaaga aagcggtttc ggtgcgtttt 600
attatccaca ctgaaaaact tgattccagt gacaagagat atggtggaaa actttaccag 660
gatgctcaag tcgcaattga tgagatcaag agaactcatc ccgatatcaa gttcatctca 720
tatgatgaaa tagttgcctt aggccgaggc tccaagttga atgctattcc tcccaaagct 780
gatgaccttt cgtgtattat gtacacatca ggatctacag gcactcccaa aggtgtggtt 840
ttaagtcata gaaacgtact tgccggtatt ggtggtgcct ccactttagt tcctagaagc 900
ctaattaatg ggaaagaccg aatcattgca tttcttccat tggcccatat ttttgagtta 960
gtatttgaat tgatctcctt gtggtggggt ggatgtttag ggtatgctaa cgtgaagact 1020
ttgactgatg cttccatccg aaattgccaa tccgacctga aggccttcaa accaacgatc 1080
atggttggtg ttgctgctgt ttgggagtcg gttagaaaag gtattcttga tcagctgaac 1140
aaatcccctt ttctattaca aaaagtattt tggggagcct acaaaagcaa acaagcaatg 1200
aagtactgcc atattcctgg cacttcaatt attgatgcgg taatttttcg caaggtaaag 1260
gctgctactg gtggtgaaat tcgccttctg cttaacggtg gatcacccat ttctgcggat 1320
acccaacgat ttatcacaaa ccttcttgct cccatgctct taggttacgg tttaacagag 1380
acagttgcta atacatgtat cacggatatc gacaactttg agtttgatgt tgccggtgca 1440
ttgactggcg ctgttaccgt caaattaata gacgttccag aagctggtta ttttgcaaag 1500
aataaccaag gagaagtgtt gattcaggga gcatgtgtta caaaagagta ctataagaat 1560
gagcaagaaa ctgcaagtgt ttttgattac gaaaaaggtt ggttcagtac tggtgatatt 1620
ggagaatgga cgtcgtcggg gcagctaaaa gtaatagacc gtaagaaaaa tctgattaaa 1680
acactgaatg gtgagtatat cgctttggaa aagatagagt ccgtatatcg atctaacagc 1740
tatattcata atgtttgctg ctatgctgat cagaataaat ccaaaccagt agcaatcgct 1800
gttccaaacg agaccacgtt gcgcaagctt gctgttcaac tgaagctagc aagcgctgtt 1860
gatgaggtcg acttagcaaa ggtagtccac gattctaaat tgatctccaa agtacaccaa 1920
tctcttctgg agacggctaa gcagcaaggt ctaactggaa tagaattgat tcagggtgtc 1980
gttattttgg atgaagaatg gactcctcag aatgggtttg taacctcagc tcaaaaattg 2040
caacgcaaga aaattttgga gagtgtcaag gatcgtgtcg atgaagtata taggcaaaac 2100
agttga 2106
<210> 5
<211> 2226
<212> DNA
<213> An artificial sequence
<400> 5
atgtcacatc tcaaaaagat ccaggatagg actccggtcg agagtttgtc acctcaggac 60
aaaaaggaaa tcaagtcgct ctttgacagt ctgccattgc cctcttctga cctagctaac 120
tcctacgcag tcccagggtc agccaaaact ggatattcac ctacattcag aaatagttat 180
gtcagaaacg gatcgttgat cgagacgcta catccttctc tgaggactct gcatgagttg 240
ttcagtaact ctgttcagtt gtatggagaa agggactgtt tgggttctag actttatgac 300
catgatgtaa aggacggtta tgacgattat ttcacgtttg agaactacag gacgatttgc 360
gaacgaaagt ctaatttggg agctggtata attcattccg tgctagataa cgaatacaga 420
attgacccaa aagacggcgg ttttgacctt gcagattata acaccaataa cttcattgtc 480
agtctgtatg gtagaaatag ggctgaatgg gtgctatctg atttggcctg tcaaacctac 540
agtttaccgg acactgcatt gtatgataca ttaggaccca caacttccgc ttatatcctt 600
gagctgacaa agtctccagt agtaatttgc tgcgctgaga agattgaaaa acttattgag 660
ctcaagacaa acaatccaga gtcactcaag cattttatca ccatcatttc tatggataat 720
cttgattttc aagatttttc catcaacgac cttataaaaa gagccaacag tgttcaaatt 780
aaactgttag atttgggaca aacagaagag ctgggtaagg cttctcctgt ggcagaaata 840
cctccacttc cttcgaccat atacactatt tcgtttacct caggaaccac tggagttccc 900
aagggagtag tattgacaca caaaatagcc actgcagcag ccacgtttgc tttatcgcat 960
atagggcttc ctgacagcgg aagaacgctg agtattcttc ccttggctca tatttttgaa 1020
aggcaagtat ccaatctagc gcttgtcgct ggagtagctt taacattccc acatctccca 1080
ggcccagagc atattgttcc aaaccttcgt ataagtaaac cttgtgctct aactgctgtg 1140
ccgagattgt ataacaagtt tgaaagtgca atcaagtctt cccttctaag tggaccggag 1200
acaattaccc agaagctggt ttccgccata attagccaaa acatccgaac tcaatcggcc 1260
aaagatggga ataagggcaa caattttatt tcacgacaat tggtcacaaa gaaaatcagg 1320
gcatctttag gattagataa ctgtcaattc ttggttactg gctcagcacc cattgaccca 1380
gaaacgatga agttcttgaa gggatctcta ggagttggat ttatgcaagg ttatgggcta 1440
acggaatgtt atgctggaat ctgcatctca tcagcttatc tgaaagaaaa tggttcctgt 1500
ggtgccattg ggatatctgc tgaaatgagg ttgagagatg tgcctgaaat gaactatttc 1560
tctggaaaac aacttgcgga tgggtcgtat cacggtgagc tgcaattacg tggtcctcag 1620
gttttcagct actactataa aagacccgat gagactgaaa aagcatttga taaagacggc 1680
tggttctgta ctggagatat tgctagaatt gacaaaaatg gaaagcttta cattattgac 1740
agagttaaga attttttcaa attatcccaa ggggagtacg taacaccaga gaaaattgag 1800
aacatttacc ttagtagttc tcctttgatt tcacaagttt tcattcatgg tgactctctg 1860
cattcttttt tggtggctgt tgttggtgta gatgaaacgt ttttcaataa tttgagatca 1920
gttgacccgt caatcattaa gaattatgaa ctcaaatcca ctgaagacac cattgaaaaa 1980
tgcaatgcta ataaagattt gaagagatct cttctctttc tattcaataa gagtgtcgaa 2040
agtgctggat tgttgggttt tgaaaaaatc cacaactttc accttgcgtt tgaaccgtta 2100
aagattgaag acgatactct gactcctacg tttaaacttc gtagggttca agccaagcac 2160
aaatttgaca ccgaattggc taatttgtac aatgagaaga gtcttctgag ggagactaag 2220
atgtag 2226
<210> 6
<211> 2112
<212> DNA
<213> An artificial sequence
<400> 6
atgttcaaaa ttgaatcgat caaaagtcag tcgccgcagg tggccattga caaggagaga 60
aaagctacca agtttgatat caacaagatg tttgaatttt tggagagtgg caaggatgaa 120
gctgctctca caaagtctct gatgcaacaa atcgaaagag acaccatctt gaaaactaat 180
gccagttatt acgacttgac gaaagaccag cacagagagc tcacagctca gaagatcgcc 240
agattggcta cttatattga aaaggatgcc ccattctttg agaacttcca aaagagactg 300
aatctcattg ctattgttga tccacaacta ggtacgagag ttggggtcca tcttggattg 360
tttctgagtg caattagagg caacggtacg gaggaacagt tcaagtattg ggctttcgaa 420
cgtggtgccg cctacttgaa ggatgtgtat ggctgtttcg gtatgactga attagcccac 480
gggtcaaatg tggcgggtct ggaaaccaca gctacatttg atcaaaagac taaagagttt 540
gaaatcaaca cccctcattt gggtgccacc aaatggtgga ttggaggagc tgcccattct 600
gcaaatcact gtgtggtgta tgccaggtta attgtcagtg gtaaggatta cggagtgaaa 660
acttttgttg tccccatcag agacagaaat cataacttac attccggtgt ggctattggt 720
gacattggcg ctaagatggg cagagatggt attgacaacg gttggattca atttaccaac 780
gtccgaatcc cgatgaacta catgctgtcc aagtttacta aagtggactc agagacagga 840
gatgtagagg ttccaccttt ggagcagcta gcgtacggag ctttgctggg tggaagagtt 900
acaatggtta ccgattcttt tagaatggca cagcgtttca tcaccattgc tctaagatat 960
tccgttggaa gacgacagtt tggcgccaaa aattcctcag aggaactcaa attgattgac 1020
tacccattgc accagcgtcg tcttcttcct tacttggccc tgacctatgc tctgtcaata 1080
agttcttttg atttgtccca aacttatgac tccgttttga gtaatctaga tgccgccgga 1140
aagtcccaag atttttctaa gttgggccaa gcgattgccg gacttaagaa ccttttctgt 1200
gcttctgctt ctctgaaatc tactgcgacc tggtatgttg cccagctgat tgacgagtgt 1260
agacaggcat gtggtggaca tggatattcc tcgtattccg ggtttggtaa agcatataat 1320
gattgggttg ttcaatgtac ctgggaggga gataacaaca tccttgcaag taatgccggt 1380
aggattattg tgcaatctat tatcaagttg caagaaaagg aaaagaagat aaagggtgac 1440
ttgtcatact tgaatggaat cagcaatatc gacaaggaag ctattctgct tcctaacaaa 1500
caaagtatga ccaacttgtc caagttgatt aatgcctatc agggtaccat tatccgtcta 1560
ggtgtacgtt gtgccgaatc catcggaagc aaaaagtcca catgggatga catagcagct 1620
caacgagtag tcctttccaa attgaatgct gttttatata tgctgcaaca tttggttttg 1680
aaaattaaac aacttggaga cgaggaagct cacaaacaat accttgttca aattgcagct 1740
ttgtttgcaa cctcacagat agaaatgaat tttgcatctt atttcttaca attcaaggcc 1800
atcgattcgt tggaacctgt tgctgatgtt gtgtctgaac tgtgcttatc agtgcgggac 1860
caagtcattg gattgactga ctctttccaa ttttcggact actttatcaa ctctgcattg 1920
ggatcacatt ctggagacat ttacaatacc tactttgaca ctgttaacaa tctgaacaat 1980
ccgcaagtca gggacggaaa ggcggcatac tccgaggcac ttgaagccat gctacgtagg 2040
gacccactag aagtgcggga atgctttgag aagagtgaca aagtattgaa gaagttggct 2100
cctaagattt ag 2112
<210> 7
<211> 20
<212> DNA
<213> An artificial sequence
<400> 7
ggttggtact atgtccaaca 20
<210> 8
<211> 3306
<212> DNA
<213> An artificial sequence
<400> 8
atgtccgcta aagctatttc cgaacaaact ggtaaagaat tattatacaa gtacatttgc 60
accacctcag ccatacaaaa cagattcaag tatgcaagag ttacaccaga taccgactgg 120
gcccatttgt tacaagatca cccttggttg ttatctcaat cattggttgt caaacctgac 180
caattgatta aaagacgtgg taaattgggt ttagtcggtg taaacttgag tttagatggt 240
gttaagtctt ggttgaagcc aagattaggt catgaagcta cagttggtaa agcaaagggt 300
ttcttgaaaa atttcttgat cgaaccattc gtacctcact cacaagctga agaattttac 360
gtttgtatct atgcaactag agaaggtgac tatgtcttgt ttcatcacga aggtggtgtt 420
gacgtcggtg acgttgacgc caaagctcaa aagttgttag taggtgttga tgaaaagtta 480
aacacagaag acatcaagag acatttgttg gtacacgccc cagaagataa aaaggaagtt 540
ttggcttcct ttataagtgg tttgtttaat ttctacgaag atttgtactt cacctacttg 600
gaaattaacc ctttagtagt tactaaggat ggtgtctata tattggactt agctgcaaaa 660
gtagatgcaa ctgccgacta catctgtaag gttaagtggg gtgacattga atttccacct 720
ccattcggta gagaagcata tccagaagaa gcctacattg ctgatttgga cgcaaaatct 780
ggtgcctcat tgaagttaac attgttgaac cctaagggta gaatatggac tatggttgct 840
ggtggtggtg caagtgtcgt atattctgat acaatctgcg acttgggtgg tgttaacgaa 900
ttagctaact acggtgaata ctcaggtgca ccatccgaac aacaaactta tgattacgct 960
aagaccatct tgagtttaat gactagagaa aagcatcctg aaggtaaaat tttgatcatc 1020
ggtggttcta tagcaaactt cactaacgtt gccgctacat tcaagggtat agtcagagct 1080
atcagagatt atcaaggtcc attgaaggaa cacgaagtta caatattcgt cagaagaggt 1140
ggtcctaact accaagaagg tttaagagta atgggtgaag ttggtaaaac tacaggtatc 1200
ccaattcatg tatttggtac tgaaacacac atgactgcca tcgttggtat ggctttaggt 1260
catagaccaa ttcctaatca acctccaaca gcagcccaca ccgccaattt cttgttaaac 1320
gcttccggta gtacctctac tccagcacca tcaagaactg cctcattctc cgaaagtaga 1380
gctgatgaag ttgctccagc taagaaagca aaaccagcca tgcctcaaga ctccgttcca 1440
agtcctagat cattgcaagg taaatcagca acattatttt ccagacatac caaagccatt 1500
gtatggggta tgcaaacaag agctgttcaa ggcatgttgg atttcgacta tgtttgtagt 1560
agagatgaac catctgtcgc tgcaatggta tatcctttta ccggtgacca taaacaaaag 1620
ttctactggg gtcacaagga aatattaatc ccagttttta aaaacatggc cgatgctatg 1680
aaaaagcatc ctgaagttga tgtattgatt aacttcgctt cattaagatc cgcttatgat 1740
tctactatgg aaacaatgaa ctacgcacaa attagaacca tagctatcat tgcagaaggt 1800
ataccagaag cattgactag aaagttaatc aaaaaggccg atcaaaaagg tgtcactata 1860
atcggtccag ctacagtagg tggtataaaa cctggttgtt ttaagatcgg taatactggt 1920
ggcatgttgg ataacatatt ggcatcaaaa ttgtatagac caggttccgt agcttacgtt 1980
tcaagaagcg gtggtatgag taacgaattg aacaacataa tttcaagaac cactgatggt 2040
gtttatgaag gtgtcgctat tggtggtgac agatacccag gttctacttt tatggatcat 2100
gttttgagat atcaagacac acctggtgtc aaaatgatcg ttgtcttagg tgaaataggt 2160
ggtactgaag aatacaaaat ttgcagaggt ataaaggaag gtagattgac aaaaccagta 2220
gtttgttggt gcattggtac ttgtgcaact atgttttctt cagaagttca attcggtcat 2280
gcaggtgcct gcgctaatca agcatctgaa acagcagttg ccaaaaacca agccttaaag 2340
gaagctggtg tttttgtccc tagatcattc gatgaattgg gtgaaatcat tcaatccgta 2400
tatgaagact tagttgccaa gggtgctatt gtcccagctc aagaagtacc tccacctact 2460
gttcctatgg attactcatg ggcaagagaa ttgggtttga tcagaaagcc agctagtttt 2520
atgacctcta tctgtgatga aagaggtcaa gaattgatct atgctggtat gcctatcact 2580
gaagtcttca aggaagaaat gggtatcggt ggtgtattgg gtttgttgtg gttccaaaga 2640
agattaccaa agtactcatg tcaattcata gaaatgtgct taatggttac agctgatcat 2700
ggtccagctg tttctggtgc ccacaacacc ataatctgcg ctagagcagg taaagatttg 2760
gtttcttctt tgacctctgg tttgttaact attggtgaca gatttggtgg tgcattggac 2820
gccgctgcaa aaatgttttc aaaggctttc gattccggta taatcccaat ggaatttgtt 2880
aataagatga aaaaggaggg taaattaatc atgggtatcg gtcatcgtgt taagtcaatt 2940
aataaccctg atatgagagt ccaaatattg aaggacttcg taaagcaaca cttcccagca 3000
acacctttgt tagattacgc cttagaagtt gaaaagatta caacctctaa aaagccaaat 3060
ttgatcttga acgttgatgg ttttataggt gtcgctttcg tagacatgtt aagaaactgt 3120
ggttctttta ctagagaaga agccgatgaa tatgttgaca ttggtgcttt gaatggtata 3180
tttgtcttag gtagatcaat gggttttatt ggtcattact tggatcaaaa gagattaaag 3240
caaggtttgt atagacaccc ttgggacgat atttcctacg ttttgcctga acacatgagt 3300
atgtaa 3306
<210> 9
<211> 20
<212> DNA
<213> An artificial sequence
<400> 9
tgtgtctttg aagcacacag 20
<210> 10
<211> 20
<212> DNA
<213> An artificial sequence
<400> 10
ttgtggctat ggcttgaatg 20
<210> 11
<211> 1239
<212> DNA
<213> An artificial sequence
<400> 11
atggctcatg caaaaatttc agtgaagact ccattagtgg agatggatgg tgatgaaatg 60
acgagaatca tctggaaact catcaaagat gagttgattc ttccattttt ggatatcgac 120
ctaaagtact acgacttggg aatcgagtat agagatcaaa ccgacgacca agtcactata 180
gatgctgctg aggccatcaa gaagtatggt gtcggtgtca agtgtgccac cattacccca 240
gatgaagcca gagttgagga gtttggtttg aagaaaatgt ggctgtctcc caacggtaca 300
atcagaaaca tattgggcgg aaccgttttc agagagccaa ttgtcattga caacatccca 360
agaattattc ctcagtggga gaagccaatt atcattggaa gacatgctta cggtgaccaa 420
tatagagcca ccgatttgct gattccaaaa gctggtgagt tgaagttggt tttcactcca 480
aaggacggat ctgaccctgt cgagacaaag gttttcgact acccatctgc cggtgtcgct 540
ctgactatgt acaacttgga tgattctatc cgagactttg ctctttcctc cttcaaactt 600
gctctagaaa agaaagtgaa cctgttctcg accaccaaga ataccatcct gaagaaatat 660
gatggtagat tcaaagacat ctttgacgaa acgtacgaaa cacaattcaa agaatctttt 720
gagaaggccg gtatttggta tgagcaccgt ctcattgacg atatggttgc tcagatgttg 780
aaatcaaagg gaggctatat cattgctatg aagaactacg atggtgacgt gcaatccgac 840
attgttgccc aaggtttcgg atctttaggt ttgatgacct ctgttttgac gaccccagat 900
ggaactgctt ttgagagtga agctgctcat ggaaccgtca ctagacatta cagacaacac 960
cagcaaggta aggagacctc caccaactct attgcctcta tcttcgcttg gactagaggt 1020
ttaattcaaa gaggactact ggacaacact cttcctgttg ttgagtttgg tcaacttctg 1080
gaaaatgcca ctatcaacac agttaaattg gatggaatca tgaccaaaga tctcgctctt 1140
gcaagaggtg agactgacag atcttcttat gtgaacactg aggagtttat caaagctgtt 1200
gctaagagat tgactagtga gtttgaagcc aagttttag 1239
<210> 12
<211> 945
<212> DNA
<213> An artificial sequence
<400> 12
atgccatcta ccactaatac tgctgcagca aacgtaatag aaaaaaagcc agtctcgttt 60
tctaatatcc tattgggtgc ctgtttaaac ttgtcagagg tgactacatt agggcaacct 120
ttggaggttg ttaagaccac aatggctgca aacagaaact tcacattttt agaatctgtt 180
aagcatgtct ggtcaagagg tggtatcttg ggttactacc aaggtttgat tccatgggca 240
tggatcgaag cctccactaa aggtgctgtg ttgctgttcg tgtcagctga ggctgagtat 300
cgtttcaaaa gtttggggtt gaacaacttt gcctcaggta tattaggtgg tgtcacgggt 360
ggtgtcactc aagcctactt aaccatgggg ttctgtacct gtatgaaaac ggtggaaatt 420
acaagacata aatctgcctc cgcaggtggt gtcccacaat cttcttggag tgtgttcaag 480
aatatttata aaaaggaagg tattagaggt attaataagg gtgttaatgc tgttgctatt 540
agacaaatga ccaactgggg ttctcgtttt ggtttgtcca gactagtgga agatggtatc 600
agaaagatca ccgggaaaac caataaagac gacaagttga atccgttcga gaaaattggt 660
gccagtgctt taggtggtgg tttaagtgct tggaatcaac caatcgaagt cattagagtt 720
gaaatgcaat ctaagaagga agatccaaac agaccaaaaa atttgactgt tggtaagaca 780
tttaaataca tctatcaatc aaatggtcta aagggtcttt accgtggtgt caccccaaga 840
attggtttag gtatctggca aactgtcttc atggttggtt ttggtgatat ggcgaaggaa 900
tttgtcgcca gaatgactgg tgaaacccca gttgccaaac attag 945
<210> 13
<211> 3525
<212> DNA
<213> An artificial sequence
<400> 13
atgagtccta tcactaggga ggagaggttg gagagaagga tccaagatct ttacgctaac 60
gacccacagt tcgctgccgc caaaccagct accgctatca ccgctgctat cgaaaggccc 120
ggacttccac ttccacagat catcgaaacc gtcatgactg gttatgccga tagaccagct 180
cttgcccaga ggagtgtcga attcgtcact gacgccggta ctggacacac cactttgagg 240
ttgttgcctc acttcgaaac catcagttat ggtgaattgt gggatagaat cagtgccctt 300
gccgacgtct tgagtaccga acagaccgtt aagcccggag atagagtctg cttgcttgga 360
ttcaacagtg tcgactatgc cactattgac atgacccttg ctaggttggg agctgttgct 420
gtccctttgc agacctctgc cgctattacc cagcttcagc caattgtcgc cgaaactcaa 480
ccaactatga tcgctgcctc tgttgatgct ttggctgatg ccaccgagct tgctctttct 540
ggtcaaaccg ccactagggt ccttgtcttt gaccaccata gacaagtcga tgctcataga 600
gctgctgtcg aatctgctag ggaaaggctt gccggatctg ctgtcgtcga aaccttggct 660
gaggctattg ccagaggaga tgttccaaga ggtgcctctg ctggtagtgc tcccggaacc 720
gatgtctctg atgactctct tgccttgctt atctatacct ctggatctac cggagcccca 780
aagggagcca tgtacccaag aagaaacgtc gccaccttct ggaggaagag gacttggttc 840
gaaggaggat acgagccatc tatcactctt aatttcatgc caatgtctca cgtcatggga 900
aggcagatct tgtatggtac cctttgcaat ggtggtaccg cctacttcgt tgccaagagt 960
gacttgagta ctcttttcga ggacttggcc ttggttaggc ctaccgagtt gaccttcgtt 1020
cctagggtct gggacatggt cttcgacgag ttccagagtg aggtcgatag aagacttgtc 1080
gacggagctg atagggttgc ccttgaggcc caagtcaaag ccgaaatcag aaacgacgtc 1140
cttggtggta ggtacacctc tgccttgacc ggaagtgctc caatcagtga cgagatgaag 1200
gcttgggtcg aggagctttt ggatatgcac ttggttgaag gatacggatc taccgaggcc 1260
ggaatgatct tgattgacgg agctattaga aggccagccg tcttggatta caagttggtc 1320
gacgtcccag acttgggata cttcttgact gatagacctc acccaagagg tgaacttctt 1380
gtcaaaactg atagtctttt ccccggatat tatcagagag ctgaagtcac cgctgatgtt 1440
ttcgacgccg acggtttcta tagaaccggt gacatcatgg ctgaggttgg accagaacag 1500
ttcgtctacc ttgacagaag gaataacgtc ttgaagttga gtcaaggaga atttgttact 1560
gttagtaagt tggaagctgt cttcggagac tctcctttgg ttagacagat ctacatttac 1620
ggaaattctg ctagagctta ccttcttgcc gtcatcgtcc ctactcaaga agccttggac 1680
gccgtcccag ttgaggagtt gaaggctaga ttgggagact ctttgcaaga agtcgccaaa 1740
gctgccggtt tgcagtctta cgagatccca agagacttta tcattgagac cactccttgg 1800
acccttgaga acggacttct taccggaatt agaaagcttg ctagacctca gcttaagaaa 1860
cactatggtg agcttttgga gcagatctac actgacttgg cccatggtca agccgatgag 1920
cttaggtctc ttaggcagtc tggagccgat gccccagttc ttgtcactgt ttgcagagcc 1980
gctgccgctt tgttgggtgg atctgcttct gatgtccagc cagatgccca tttcactgat 2040
cttggtggag acagtctttc tgccttgtct ttcaccaatt tgttgcatga gatttttgat 2100
attgaggtcc cagttggagt cattgtctct ccagccaacg atttgcaagc tcttgctgac 2160
tatgtcgagg ctgctaggaa acccggatct tctaggccta cctttgcctc tgttcacgga 2220
gctagtaacg gtcaagtcac cgaagttcac gccggtgact tgtctcttga caagttcatc 2280
gacgccgcta ctcttgctga agctcctaga ttgccagctg ccaacactca agttagaacc 2340
gttttgctta ctggagccac cggatttctt ggaagatacc ttgcccttga gtggcttgaa 2400
aggatggact tggtcgacgg aaagcttatc tgccttgtta gagccaagtc tgacactgaa 2460
gctagggcca gattggacaa gacctttgac tctggtgacc cagagttgct tgcccactac 2520
agagccttgg ctggagatca cttggaggtt ttggccggtg ataagggtga ggccgacctt 2580
ggattggata gacaaacttg gcagaggctt gccgacactg ttgatttgat cgtcgaccca 2640
gccgctcttg tcaatcacgt ccttccttac tctcagttgt tcggaccaaa cgcccttgga 2700
actgctgaac ttcttagact tgcccttacc tctaagatta aaccatacag ttacacctct 2760
accatcggag tcgccgacca gatcccacca agtgccttca ctgaggacgc cgacattaga 2820
gttatctctg ctaccagagc cgttgacgac tcttacgcta acggatactc taactctaag 2880
tgggccggag aagtcttgct tagagaagcc cacgatcttt gcggtcttcc agttgccgtt 2940
tttagatgtg atatgatctt ggccgatacc acttgggctg gacagttgaa cgttccagat 3000
atgttcacta ggatgatttt gtctcttgcc gccaccggaa ttgcccccgg atctttctat 3060
gagcttgccg ccgatggagc taggcagagg gcccactacg acggattgcc agttgagttc 3120
attgccgagg ccatctctac tttgggtgcc cagtctcaag atggtttcca cacctatcac 3180
gttatgaatc catacgacga cggtatcggt ttggatgagt tcgtcgattg gttgaacgag 3240
tctggttgtc caatccagag aatcgccgac tatggtgact ggcttcagag gtttgaaacc 3300
gccttgagag ccttgccaga tagacaaagg cacagttctt tgcttccatt gcttcataat 3360
tatagacaac cagaaagacc agttagaggt tctattgccc caactgatag atttagggct 3420
gccgttcaag aagccaagat cggtccagac aaggatatcc ctcatgtcgg agctcctatc 3480
atcgtcaagt acgtttctga cttgaggctt cttggattgc tttga 3525
<210> 14
<211> 1035
<212> DNA
<213> An artificial sequence
<400> 14
atggttcaag ataccagttc tgcctctacc tctcctatcc ttactagatg gtacatcgac 60
accagaccat tgaccgcctc taccgctgct ttgccattgt tggagactct tcagccagct 120
gatcagattt ctgtccagaa gtactatcac cttaaagata aacatatgag tttggctagt 180
aaccttttga aatatctttt tgtccatagg aactgcagaa tcccatggag tagtatcgtc 240
atctctagga ccccagaccc tcataggaga ccatgctaca tcccaccttc tggtagtcaa 300
gaagactctt tcaaggacgg ttacaccggt atcaatgtcg agttcaacgt cagtcaccaa 360
gccagtatgg tcgctattgc cggaactgcc tttaccccta actctggagg agatagtaag 420
ttgaagccag aggtcggaat cgacatcact tgtgtcaatg agaggcaagg aagaaacgga 480
gaggagagga gtcttgagag tttgaggcaa tatatcgata tcttctctga ggtcttcagt 540
accgccgaga tggctaacat tagaaggttg gacggagtct ctagttcttc tttgagtgcc 600
gatagattgg tcgactacgg atatagactt ttttacactt actgggcctt gaaggaggcc 660
tacatcaaga tgaccggaga ggctttgctt gccccttggt tgagggaact tgagttcagt 720
aacgttgtcg ccccagctgc tgttgctgag tctggagaca gtgctggaga tttcggtgag 780
ccatacaccg gagtcagaac taccttgtat aaaaatttgg tcgaggacgt cagaatcgaa 840
gtcgccgctt tgggaggaga ctatttgttc gccactgctg ctaggggagg aggtatcgga 900
gcttcttcta gacccggagg tggaccagat ggaagtggaa ttagatctca agatccttgg 960
aggccattca agaagttgga cattgagagg gacatccagc catgcgccac cggagtctgt 1020
aattgcttgt cttga 1035
<210> 15
<211> 1986
<212> DNA
<213> An artificial sequence
<400> 15
atgaactact tccttaccgg aggtaccgga ttcatcggta ggttcttggt cgagaagttg 60
cttgccagag gaggaactgt ctacgtcttg gttagagagc agagtcaaga taagttggaa 120
aggcttaggg aaaggtgggg tgctgacgac aaacaagtca aggctgtcat cggagacttg 180
acctctaaga accttggtat cgacgccaag acccttaaat ctttgaaggg aaacattgat 240
cacgtcttcc acttggccgc tgtctatgat atgggagccg acgaggaggc ccaagccgct 300
accaacatcg aaggaactag ggctgctgtt caagctgctg aagccatggg agccaagcac 360
ttccaccacg tttcttctat cgccgctgcc ggtcttttca agggtatctt tagagaggac 420
atgttcgagg aagccgaaaa gcttgaccac ccttacctta ggaccaagca cgaaagtgag 480
aaggtcgtta gagaagagtg taaggtccct tttagaatct atagacccgg aatggtcatc 540
ggtcatagtg agaccggaga gatggataag gtcgatggac cttactattt cttcaagatg 600
atccagaaga ttagacacgc ccttccacag tgggttccta ccatcggtat cgagggaggt 660
aggcttaaca tcgtcccagt tgacttcgtc gtcgatgctt tggaccacat cgcccacttg 720
gagggagagg acggtaactg cttccacctt gttgactctg acccttacaa ggtcggagag 780
atcttgaata tcttctgcga ggccggtcac gcccctagaa tgggaatgag aatcgacagt 840
agaatgtttg gtttcatccc accatttatc agacaatcta ttaagaatct tccaccagtt 900
aagaggatca ctggagcctt gttggatgac atgggaatcc ctccaagtgt catgtctttt 960
attaactacc ctaccagatt tgacactaga gagcttgaga gggtccttaa gggaactgac 1020
attgaggtcc caagacttcc tagttacgcc ccagttatct gggactactg ggagaggaac 1080
cttgacccag acttgttcaa ggatagaacc ttgaagggaa ctgtcgaagg taaggtctgc 1140
gtcgttaccg gagccacctc tggtatcgga ttggccaccg ctgagaagtt ggccgaagct 1200
ggagccattc ttgtcatcgg tgctagaacc aaggaaaccc ttgatgaggt cgctgcctct 1260
ttggaagcca aaggaggtaa cgtccacgcc taccaatgcg atttctctga catggacgac 1320
tgcgataggt tcgtcaaaac cgtcttggat aaccacggac acgttgacgt ccttgtcaac 1380
aacgccggta ggagtattag aaggagtttg gctttgtctt tcgatagatt tcatgatttt 1440
gaaaggacta tgcaattgaa ttatttcggt agtgttagat tgatcatggg attcgctcca 1500
gctatgcttg agagaaggag gggtcacgtc gttaacatct cttctatcgg tgttcttacc 1560
aacgccccta ggttcagtgc ctacgtctct tctaagtctg ctttggacgc cttcagtagg 1620
tgtgccgccg ccgaatggtc tgacagaaac gtcactttta ctactattaa catgccattg 1680
gtcaagaccc caatgatcgc cccaaccaag atttacgact ctgtcccaac ccttacccca 1740
gatgaggccg cccaaatggt tgctgacgct atcgtctata gacctaagag aatcgccact 1800
agacttggag tcttcgccca agttcttcac gctcttgccc caaagatggg agagattatt 1860
atgaataccg gatacagaat gttcccagat tctccagccg ctgctggttc taagtctggt 1920
gagaagccaa aggtctctac tgagcaagtc gccttcgccg ccatcatgag aggaatttac 1980
tggtga 1986
<210> 16
<211> 20
<212> DNA
<213> An artificial sequence
<400> 16
cacgagccga gtaataaccg 20
<210> 17
<211> 20
<212> DNA
<213> An artificial sequence
<400> 17
cgaaagtatt tacagtaccg 20
<210> 18
<211> 1539
<212> DNA
<213> An artificial sequence
<400> 18
atgctggaat atactcaagt tgaagaaatt ggttctctcg tagataaagc tcgacaagtt 60
tttgatagta atgtattact aactgtccaa aatcgtttga atcaattacg gaatctgtac 120
tatgttttgt tggaccatca gacacagttt gaggatgccc tcagcaagga cttcaacagg 180
tcccgatttg agacgtctag attggagcta gcacaagtat ttggagaaat tctttatgtg 240
atgcagcatc tggagtcatg gagcaaaccc caaaaagtcg actacctccc tttatctttc 300
ggtactactt atagcacagt ggaaaagatt cctcttggtg taatacttat cattgcaccg 360
ttcaactacc cgatcgttct ttctttgtct cctatcattg gagccattgc tgccggaaac 420
actgttgttt tcaagccgtc tgaacttact cccaactgta gtacactcct aactgaggtg 480
ttacagagtt gttttgatta cccaattgta tccgtagtta atgggggaat caccgagacc 540
cagaaattgt tggaaccgaa gtttgacaag ataatgttca ccggaagtgg acatgtagga 600
aaaattattt ctaaagcagc tgctgagcac cttactcctg ttatcttaga attgggcgga 660
aagtctcctt gctttctgac ttccaattgt aagactacca aaattaaagc tctcctgagt 720
cgaatcattt ggtcttcatt tgtcaatagt ggacaaacct gcgtggcggt agactatcta 780
ttagttcacg aaagtattta cagtaccgtg gtacaagaat ctactaagat actaaaggaa 840
ttctattgca atatcacaga gaaaagtgat tttactcatc ttattgatcg aaagtcattc 900
aaacgaacta tgaccacatt gcaaagaacc aagggcaaaa agatcagttt cggtgtttct 960
catgaagaca ctaactttat acctcctaca ttgatttgtg acgtatcctg ggacgatgag 1020
accatgcaat ctgaaaattt tgcgcccatt cttcccatca tcaaatactc cagtttagaa 1080
gatgttgtga gcgaggtgaa aactgagcat gacaccccgc tagcatgtta catcttttct 1140
gaagaccctc aagaacaaag gtacattcta aacaatttac gatcgggagg agtttgtata 1200
aatgaaacaa tgatgcacgt tggactttac actgcacctt tcgggggaat aggtgactca 1260
ggctatggaa attaccatgg gaagtggtca tttgattctt ttagtcactc aagaaccgtt 1320
ctaaaacaac cgttgtgggc agagttccta attaaagctc gttatcctcc ttacacaaga 1380
aaaaatagag cgactctgga gctcttagat aaaggtgtgg tttggtttga ccgttccggt 1440
aacgtccctt caagaagatc gtatttaacg aaagttattg gatactgcgg attgatggtt 1500
acaattgctg ctgcattaat tggtaaactt gttttttaa 1539
<210> 19
<211> 1074
<212> DNA
<213> An artificial sequence
<400> 19
atgcaaggaa tctctgctag tccagagagg atgaacgccc agcaaagagc cgcccacgtt 60
agacaagttg tcttggccag aggagacgag cttaggagga ggttccctct tttgagacac 120
caagatgccc ttggtgctgg aatcttggcc ttcgccttgt ctggaatgtt gggatctgcc 180
cttttgtacg tcaccggtca tcttgcttgg tgggcttgct tgttgcttaa cgccttcttc 240
gcctctctta cccacgagtt ggagcatgac cttattcatt ctatgtactt tagaaagcag 300
aggttgcctc ataaccttat gcttggattg gtttggttgg ctagaccatc tactatcaac 360
ccatgggtta gaaggcacct tcatcttaac caccacaagg tcagtggatc tgagagtgac 420
atcgaggaga gagctatcac caatggtgag ccatggggaa tcgctagact tttgatggtc 480
ggtgacaaca tgatggctgc cttcattaga cttcttaggg ctcccggagc taggagaaag 540
ttgggaatcc ttgttagaac cttggccgtt tatgcccctt tggccttgtt gcattgggga 600
gcttggtacg tcttccttgg attccacggt gctaacggag tcgccgcctt gcttggatct 660
ccaatccagt ggtctcaaga taccgccagt ttgatgcatt acgtcgacat cgccgtcgtc 720
gtcatcatcg gaccaaacgt tttgagaact ttctgcttgc attttgtctc ttctaacatg 780
cattactatg gagacatcga gcccggaaac gtcatccagc agacccaagt tcttaaccca 840
tggtggatgt ggccacttca agccttctgc tgcaacttcg gttctaccca tggaatccac 900
cacttcgtcg ttagagagcc tttctacatt agacagatga ctgcctctgt cgctcataag 960
gtcatggccg agatgggtgt tagattcaat gacttcggta cctttgctag agctaataga 1020
ttcactagac aagaaaggga agccatgcaa ccagcccaca atgctagagc ctga 1074
<210> 20
<211> 1269
<212> DNA
<213> An artificial sequence
<400> 20
atgaacgcca acgacaatgt tgtcatcgtc ggtaccggac ttgccggagt tgaagttgcc 60
ttcggtttga gggcttctgg ttgggagggt aacattagat tggttggaga cgccactgtt 120
atccctcacc acttgcctcc tctttctaag gcttacttgg ctggtaaggc cactgccgag 180
tctctttacc ttaggacccc agacgcctac gccgcccaga acatccaact tttgggaggt 240
acccaagtta ccgctatcaa tagagatagg cagcaagtta tcttgagtga cggtagagcc 300
ttggattacg atagacttgt ccttgccacc ggaggaagac caagaccttt gccagtcgcc 360
tctggagctg tcggaaaggc taacaacttt agatacctta gaaccttgga ggacgccgag 420
tgtatcagaa ggcagttgat cgccgacaat agattggttg tcatcggagg tggatacatc 480
ggattggaag tcgccgccac cgccatcaaa gccaacatgc acgtcaccct tcttgacacc 540
gctgccagag tccttgaaag ggttactgcc cctccagtct ctgcctttta cgagcacttg 600
catagggagg ctggagttga tattagaacc ggtacccaag tctgcggatt cgagatgtct 660
accgaccagc agaaggttac cgctgttctt tgcgaggacg gtactaggtt gccagctgac 720
ttggtcatcg ccggtatcgg tcttatccca aactgcgaac ttgcctctgc tgccggtttg 780
caagttgaca acggaatcgt catcaacgaa cacatgcaga cctctgaccc tcttattatg 840
gccgttggtg actgcgctag gttccattct cagttgtacg atagatgggt tagaattgag 900
tctgtcccta acgcccttga acaagctaga aagatcgccg ctatcctttg cggtaaggtc 960
cctagggatg aagctgcccc ttggttctgg agtgatcagt atgaaatcgg attgaagatg 1020
gtcggtctta gtgagggata cgataggatc atcgttagag gttctcttgc ccaaccagac 1080
ttttctgtct tctacttgca aggagacaga gtccttgctg tcgataccgt caatagacca 1140
gttgagttca accaatctaa gcaaatcatc accgatagat tgccagttga accaaacttg 1200
cttggtgacg agagtgtccc acttaaggag atcatcgccg ctgctaaggc cgaactttct 1260
agtgcctga 1269
<210> 21
<211> 324
<212> DNA
<213> An artificial sequence
<400> 21
atgtctaagg tcgtctacgt ctctcacgac ggtactagga gagagttgga tgtcgctgac 60
ggagtctctc ttatgcaagc tgccgtctct aacggaatct acgacatcgt cggtgactgt 120
ggaggtagtg cttcttgcgc tacttgccac gtctacgtca acgaggcctt caccgataag 180
gttccagccg ctaacgagag ggagatcgga atgttggagt gtgtcaccgc cgagttgaag 240
ccaaactcta ggctttgctg ccagatcatc atgaccccag agttggacgg tatcgtcgtc 300
gatgttccag ataggcagtg gtga 324
<210> 22
<211> 816
<212> DNA
<213> An artificial sequence
<400> 22
atggaaatca ctagaattaa ggagttgaag gtcatcgacg ccttcgtcag aatcggacca 60
cttatggatc cagctagtta tccacagtgg gcccagcaat tgatcgagga ctgcagagaa 120
tctaagagga gggttgtcga gcacgagttc tacgctagat tgagggacgg acagcttaag 180
cagtctacca ttagacagta ccttatcggt ggatggccag tcgtcgagca gttcagtctt 240
tatatggccc acaaccttac caagactaga tacggtagac accaaggaga agatatggct 300
agaaggtggc ttatgaggaa cattagagtc gagcttaacc acgccgacta ctgggtcaac 360
tggtgtcaag ctcatggtgt tcaccttcac gagcttcaag ctcaagaagt cccaccagag 420
cttaacggac ttaacgactg gtgctggaga gtttgcgcca ccgaaaactt ggccatctct 480
atggccgcca ctaactacgc tatcgaggga gctactggag agtggtctgc tgtcgtctgc 540
agtaccgata cctatgccca aggattccca gaagaaggta ggaagagggc catgaagtgg 600
cttaagatgc acgctcagta cgacgatgcc cacccatggg aggctttgga aatcatctgc 660
acccttgccg gtgaaaaccc taccttgggt ttgagaaccg agcttaggag ggccatctgc 720
aagtcttacg actgcatgtt tcttttcctt gaaaggtgca tgcagttgga gggaaggcaa 780
caaggaagga tgagaccagc tcttgctgct ggatga 816
<210> 23
<211> 1269
<212> DNA
<213> An artificial sequence
<400> 23
atggctactt tgaaaagaga taaaggattg gacaataccc ttaaggttct taaacaagga 60
tatctttata ctaccaacca gaggaataga ttgaacacct ctgtcttcca gaccaaagcc 120
ttgggaggaa agccattcgt cgtcgtcacc ggaaaggaag gtgccgagat gttctacaat 180
aacgacgtcg tccaaaggga gggaatgttg cctaagagga tcgtcaacac ccttttcgga 240
aagggagcta tccacaccgt cgatggtaag aagcacgtcg ataggaaggc tcttttcatg 300
agtcttatga ccgaaggaaa cttgaactac gtcagagagc ttactagaac cttgtggcac 360
gccaataccc agaggatgga gtctatggac gaagtcaaca tctacagaga gagtatcgtt 420
ttgttgacta aagtcggaac tagatgggct ggagttcaag ctcctccaga agatatcgaa 480
aggatcgcca ccgacatgga catcatgatc gatagtttca gagcccttgg aggtgccttc 540
aagggataca aggcctctaa ggaggctaga aggagagttg aggactggtt ggaggagcaa 600
atcatcgaga ctaggaaggg aaacatccac cctccagaag gaaccgcttt gtacgagttc 660
gcccactggg aggattacct tggtaaccca atggactcta ggacttgtgc catcgacctt 720
atgaacacct tcagacctct tattgccatt aataggttcg tcagtttcgg attgcacgcc 780
atgaacgaga accctattac tagggaaaag atcaagtctg agccagacta cgcctacaag 840
ttcgctcaag aagttagaag gtactaccca ttcgtcccat tcttgcccgg aaaggccaag 900
gtcgacattg acttccaagg agttaccatc ccagctggag ttggattggc cttggacgtc 960
tacggtacca cccacgatga gagtctttgg gacgacccta acgagttcag accagagaga 1020
ttcgagactt gggacggatc tcctttcgac cttattccac aaggaggtgg agactactgg 1080
accaaccata gatgcgccgg agaatggatc accgttatca tcatggaaga aaccatgaaa 1140
tactttgccg agaaaatcac ctacgacgtt ccagagcaag atcttgaggt cgaccttaac 1200
tctatccccg gatacgtcaa gagtggtttc gtcatcaaga acgttagaga ggtcgttgac 1260
agaacttga 1269
<210> 24
<211> 1224
<212> DNA
<213> An artificial sequence
<400> 24
atgtctttcg atgacgctga gctcaaacgc atatctaagg agctcgacaa gcaacttggt 60
ccagagttta tttgtacaag acctggccaa ggtggtatga aagtgtcgta tctctctggc 120
actactgcta ttagtttggc caatcacatc tttggcttta atgggtggca ttcggaagtt 180
aagagtacta cagtggattt tgtagatact cagcatggca aaatttcaat gggactttcg 240
tctgttattc gggtcacctt gaaagacggt tcttttcatg aggatattgg ttatggaagc 300
gtggaaaatg caaaatccaa ggccatagct tttgagaagt gcagaaaaga ggctatcacc 360
gacggactca agagagtttt gagatgtttt ggtaatgctt tgggtaattg tctgtacgac 420
aaggaatatt tacgaaagat ttcaaacgtt aaaactcaag ctatcacatt taatgaaggc 480
gatcttatga gacacaatca gcttgaggca cgaactctca aacaggaagc caagcttctg 540
gagattaatc aaaagaaagc taaaaacagc agcaagtcaa gaattaatgt ccctcccaag 600
cattttggtg acaatgaaga cgacgattcg catttgttca gcgatgaaat caacatcgat 660
agtgaggact ttatgaatga aattgatgat tacgagatgg atttgctgat gcaaaagaac 720
tctcagagag aaattgaaaa cgtaaacgac gatgagattg aaaataaggg tgacgctgtc 780
gacgctgtta ccaagagtaa tattgaaaat cagttcattg cccccaatag tccccagatt 840
atggacaaca tggtactgac tccagataaa atcccagcca aggttgaatt tgtttctgcc 900
aaggttgccg agaaggtcca aaacaatagt ccattgaacg tggaagaaaa gttcaaccca 960
tcattccagt ctccttcttt aagaagaact gtagatccta cgaaatcaat gcccattaga 1020
cgtacaatgg ttcaaacatc tgtgcttagt cagtccaagc agggtcctaa acgaatgatc 1080
ggaattcctc cagatacggc aaaaaggcat aagctgggat cacaaaacca aaacactgcc 1140
aacgataaac ccgaggagaa gcaattgagt cggttcaatt ctacaaaggc cccaggaaaa 1200
gaaaactctc cagcttcgaa ttaa 1224
<210> 25
<211> 20
<212> DNA
<213> An artificial sequence
<400> 25
aacgagagca gactacacca 20

Claims (22)

1. A method for constructing a recombinant pichia pastoris strain for producing fatty acids, the method comprising:
constructing a polypeptide having the sequence of SEQ ID NO:1, a sgRNA expression vector pPICZ-Cas9-gFAA1 of a targeting nucleotide sequence;
and introducing the sgRNA expression vector pPICZ-Cas9-gFAA1 into a Pichia pastoris strain, and knocking out KpFAA1 genes in the Pichia pastoris strain.
2. The construction method according to claim 1, wherein the pichia pastoris strain is integrated with a Cas9 protein.
3. The construction method according to claim 1, characterized in that the construction method further comprises: constructing a polypeptide having the sequence of SEQ ID NO:2, a sgRNA expression vector pPICZ-Cas9-gFAA2 of a targeting nucleotide sequence;
and introducing the sgRNA expression vector pPICZ-Cas9-gFAA2 into a Pichia pastoris strain, and knocking out KpFAA2 genes in the Pichia pastoris strain.
4. The construction method according to claim 1, characterized in that the construction method further comprises: constructing a polypeptide having the sequence of SEQ ID NO:3, a sgRNA expression vector pPICZ-Cas9-gPOX1 of a targeting nucleotide sequence;
And introducing the sgRNA expression vector pPICZ-Cas9-gPOX1 into a Pichia pastoris strain, and knocking out KpPOX1 genes in the Pichia pastoris strain.
5. The construction method according to claim 1, characterized in that the construction method further comprises: over-expressing the recombinant pichia pastoris strain for citrate lyase encoded by the gene MmACL derived from mice, isocitrate dehydrogenase 2 encoded by the gene KpIDP2 derived from pichia pastoris, and citrate transporter encoded by the gene ScYHM2 derived from saccharomyces cerevisiae;
wherein the recombinant pichia pastoris strain overexpresses the gene KpRAD52 from pichia pastoris and knocks out the KpFAA1 gene;
wherein, the nucleotide sequence of the KpIDP2 gene is shown in SEQ ID NO: 11.
6. The construction method according to claim 5, wherein overexpressing the recombinant pichia pastoris strain the citrate lyase encoded by the gene MmACL comprises: the gene MmACL from mice was integrated into the recombinant pichia pastoris strain.
7. The construction method according to claim 5, wherein overexpressing the recombinant pichia pastoris strain for isocitrate dehydrogenase 2 encoded by gene KpIDP2 comprises:
The KpIDP2 gene derived from Pichia is integrated into the PNSI-3 locus of Pichia pastoris genome to enable the KpIDP2 gene to be over expressed.
8. The method of claim 5, wherein over-expressing the recombinant pichia pastoris strain for the citrate transporter encoded by the gene ScYHM2 comprises: the gene ScYHM2 derived from Saccharomyces cerevisiae was integrated into the recombinant Pichia pastoris strain.
9. The construction method according to claim 1, wherein the nucleotide sequence of KpFAA1 gene is as set forth in SEQ ID NO: 4.
10. A method of construction according to claim 3, wherein the nucleotide sequence of the KpFAA2 gene is set forth in SEQ ID NO: shown at 5.
11. The construction method according to claim 4, wherein the nucleotide sequence of KpPOX1 gene is as shown in SEQ ID NO: shown at 6.
12. The construction method according to claim 5, wherein,
the nucleotide sequence of the MmACL gene is shown as SEQ ID NO: shown as 8;
the nucleotide sequence of the ScYHM2 gene is shown as SEQ ID NO: shown at 12.
13. A recombinant pichia pastoris strain producing fatty acids, characterized in that the strain is constructed by the method of any one of claims 1 to 12.
14. A method for constructing a recombinant pichia pastoris strain for fatty alcohol synthesis, which is characterized by comprising the following steps:
taking the recombinant Pichia pastoris strain for producing fatty acid as a starting strain, knocking out a fatty aldehyde dehydrogenase gene KpHFD1, and further enabling the recombinant Pichia pastoris strain to overexpress a carboxylic acid reductase gene MmCAR derived from mycobacterium marine, a cofactor gene AnnpgA derived from Aspergillus nidulans, an alcohol dehydrogenase gene ScADH5 derived from Saccharomyces cerevisiae and a fatty acyl-CoA reductase gene FaCoAR;
the nucleotide sequence of the FaCoAR gene is shown in SEQ ID NO: 15;
the nucleotide sequence of the fatty aldehyde dehydrogenase gene KpHFD1 is shown in SEQ ID NO: shown at 18;
the nucleotide sequence of the MmCAR gene is shown in SEQ ID NO: shown at 13.
15. The method of claim 14, wherein the method of constructing a building is performed,
the nucleotide sequence of the AnnpgA gene is shown in SEQ ID NO: 14.
16. The method of claim 14, wherein knocking out fatty aldehyde dehydrogenase gene KpHFD1 comprises:
constructing a polypeptide having the sequence of SEQ ID NO:17, a sgRNA expression vector ppcz-Cas 9-gHFD1 of a targeting nucleotide sequence shown in seq id no;
The sgRNA expression vector pPICZ-Cas9-gHFD1 is introduced into the recombinant Pichia pastoris strain.
17. A pichia pastoris strain for fatty alcohol synthesis, characterized in that the strain is constructed by the method of any one of claims 14 to 16.
18. A method for constructing a recombinant pichia pastoris strain for synthesizing alpha-olefin, which is characterized by comprising the following steps: taking the recombinant Pichia pastoris strain producing fatty acid as a starting strain, enabling the recombinant Pichia pastoris strain producing fatty acid to be over-expressed with cofactor protein genes CamA and CamB, and further over-expressing one or more of fatty acid decarboxylase genes PfUndB, ppUndA and JeOlet;
wherein, the nucleotide sequence of the PfUndB gene is shown in SEQ ID NO: 19;
the nucleotide sequence of the PpUndA gene is shown as SEQ ID NO: shown at 22;
the nucleotide sequence of the JeOlet gene is shown in SEQ ID NO: indicated at 23;
the nucleotide sequence of the CamA gene is shown in SEQ ID NO: shown at 20;
the nucleotide sequence of the CamB gene is shown as SEQ ID NO: 21.
19. A recombinant pichia pastoris strain for -olefin synthesis, wherein the strain is constructed by the method of claim 18.
20. The construction method of any one of claims 1 to 12 and the use of the recombinant pichia pastoris strain for fatty acid production of claim 13 in the synthesis of fatty acids.
21. The construction method of any one of claims 14 to 16 and the use of the pichia pastoris strain for fatty alcohol synthesis according to claim 17 in fatty alcohol synthesis.
22. The construction method of claim 18 and the use of the fatty alcohol-synthesized pichia pastoris strain of claim 19 in the synthesis of alpha-olefins.
CN202010516436.1A 2020-06-09 2020-06-09 Recombinant pichia pastoris strain, construction method and application thereof Active CN113774078B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010516436.1A CN113774078B (en) 2020-06-09 2020-06-09 Recombinant pichia pastoris strain, construction method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010516436.1A CN113774078B (en) 2020-06-09 2020-06-09 Recombinant pichia pastoris strain, construction method and application thereof

Publications (2)

Publication Number Publication Date
CN113774078A CN113774078A (en) 2021-12-10
CN113774078B true CN113774078B (en) 2024-04-16

Family

ID=78834274

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010516436.1A Active CN113774078B (en) 2020-06-09 2020-06-09 Recombinant pichia pastoris strain, construction method and application thereof

Country Status (1)

Country Link
CN (1) CN113774078B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102869768A (en) * 2010-03-02 2013-01-09 麻省理工学院 Microbial engineering for the production of fatty acids and fatty acid derivatives
WO2016159869A1 (en) * 2015-04-02 2016-10-06 Biopetrolia Ab Fungal cells and methods for production of very long chain fatty acid derived products

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102869768A (en) * 2010-03-02 2013-01-09 麻省理工学院 Microbial engineering for the production of fatty acids and fatty acid derivatives
WO2016159869A1 (en) * 2015-04-02 2016-10-06 Biopetrolia Ab Fungal cells and methods for production of very long chain fatty acid derived products

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Xingpeng Duan等.Free fatty acids promote transformation efficiency of yeast.《FEMS Yeast Research》.2019,第19卷(第7期),第1-7页. *

Also Published As

Publication number Publication date
CN113774078A (en) 2021-12-10

Similar Documents

Publication Publication Date Title
Gao et al. Photosynthetic production of ethanol from carbon dioxide in genetically engineered cyanobacteria
US8163516B2 (en) Selection of ADH in genetically modified cyanobacteria for the production of ethanol
GB2528177A (en) Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves
AU2011266953B2 (en) Production of Biodiesel by yeast from lignocellulose and glycerol
JP4573365B2 (en) Transformed microorganisms with improved properties
CN111434773A (en) Recombinant yeast for high-yield sandalwood oil and construction method and application thereof
US20080085341A1 (en) Methods and microorganisms for forming fermentation products and fixing carbon dioxide
CN107257851A (en) Positive influences are natural or combination of bacterial chaperonin of physiology of eukaryotic of engineering
CN101748069A (en) recombinant blue-green algae
Velmurugan et al. Metabolic transformation of cyanobacteria for biofuel production
CN105793431A (en) Processes to prepare elongated 2-ketoacids and c6-c10 compounds therefrom via genetic modifications to microbial metabolic pathways
CN104321424A (en) Expression of cytosolic malic enzyme in transgenic yarrowia to increase lipid production
CN113774078B (en) Recombinant pichia pastoris strain, construction method and application thereof
US20050106734A1 (en) Fungal micro-organism having an increased ability to carry out biotechnological process(es)
US20130059350A1 (en) Constructs and methods for increasing yield of fatty alcohols in cyanobacteria
Wang et al. Carbon-economic biosynthesis of poly-2-hydrobutanedioic acid driven by nonfermentable substrate ethanol
CN114214219A (en) Genetic engineering bacterium produced by using formate-assisted free fatty acid
CN113265343B (en) Construction method and application of recombinant hansenula polymorpha
CN112280725A (en) Recombinant escherichia coli for efficiently producing succinic acid and construction method thereof
AU2004272775B2 (en) An NADH dependent L-xylulose reductase
US20120029248A1 (en) Constructs, vectors and cyanobacteria for the synthesis of fatty alcohols, and methods for producing fatty alcohols in cyanobacteria
CN114015634B (en) Recombinant escherichia coli for high yield of succinic acid and construction method and application thereof
Sierra et al. Metabolic engineered E. coli for the production of (R)-1, 2-propanediol from biodiesel derived glycerol
CN118207107A (en) Construction method and application of engineering bacteria for high-yield fatty alcohol
CN118146967A (en) Strain for efficiently synthesizing fatty alcohol and construction method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant